[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 519
1. Gonçalves R, Saad Junior R, Dorgan Neto V, Botter M: [A rare case of pneumothorax: metastatic adamantinoma]. J Bras Pneumol; 2008 Jun;34(6):425-9
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A rare case of pneumothorax: metastatic adamantinoma].
  • [Transliterated title] Caso raro de pneumotórax: adamantinoma metastático.
  • Here, we describe two cases of lung metastasis of adamantinoma of long bones, a low-grade bone neoplasm that rarely metastasizes.
  • In both cases, the clinical presentation of the metastases was characterized by spontaneous pneumothorax secondary to tumor cavitation, a phenomenon described in only three of the studies reviewed in the literature.
  • [MeSH-major] Adamantinoma / secondary. Bone Neoplasms / pathology. Lung Neoplasms / secondary. Pneumothorax / etiology

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Collapsed Lung.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18622511.001).
  • [ISSN] 1806-3756
  • [Journal-full-title] Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia
  • [ISO-abbreviation] J Bras Pneumol
  • [Language] por
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


2. Kanakaraddi SV, Nagaraj G, Ravinath TM: Adamantinoma of the tibia with late skeletal metastasis: an unusual presentation. J Bone Joint Surg Br; 2007 Mar;89(3):388-9
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adamantinoma of the tibia with late skeletal metastasis: an unusual presentation.
  • Adamantinoma is a rare tumour of long bones that occurs most commonly in the tibia.
  • [MeSH-major] Adamantinoma / secondary. Bone Neoplasms / pathology. Femoral Neoplasms / secondary. Tibia

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17356156.001).
  • [ISSN] 0301-620X
  • [Journal-full-title] The Journal of bone and joint surgery. British volume
  • [ISO-abbreviation] J Bone Joint Surg Br
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


3. Jain D, Jain VK, Vasishta RK, Ranjan P, Kumar Y: Adamantinoma: a clinicopathological review and update. Diagn Pathol; 2008;3:8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adamantinoma: a clinicopathological review and update.
  • Adamantinoma is a primary low-grade, malignant bone tumor that is predominantly located in the mid-portion of the tibia.
  • The etiology of the tumor is still a matter of debate.
  • The initial symptoms of adamantinoma are often indolent and nonspecific and depend on location and extent of the disease.
  • Histologically, classic adamantinoma is a biphasic tumor characterized by epithelial and osteofibrous components that may be intermingled with each other in various proportions and differentiating patterns.
  • To assure the histological diagnosis, pathologists should employ immunohistochemistry for demonstrating the sometimes sparse epithelial cell nests when the radiological features are suggestive of adamantinoma.
  • There is paucity of compiled data over adamantinoma in the literature, hence authors tried to make a comprehensive review which must be of use to beginners and trained pathologists.
  • Our objective is to further define the clinicoradiologic features and pathologic spectra of adamantinoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Genet Cytogenet. 1997 Aug;97(1):5-11 [9242211.001]
  • [Cites] J Pathol. 1998 Jan;184(1):24-30 [9582523.001]
  • [Cites] Skeletal Radiol. 1998 Jul;27(7):406-9 [9730336.001]
  • [Cites] Neurosurgery. 2006 Aug;59(2):E426; discussion E426 [16883154.001]
  • [Cites] Pediatr Radiol. 2006 Oct;36(10):1068-74 [16906392.001]
  • [Cites] Virchows Arch. 2006 Nov;449(5):579-84 [17016721.001]
  • [Cites] Acta Cytol. 2006 Sep-Oct;50(5):567-73 [17017449.001]
  • [Cites] Hum Genet. 1990 Oct;85(5):513-5 [2227936.001]
  • [Cites] Diagn Cytopathol. 1988 Mar;4(1):67-70 [2454180.001]
  • [Cites] Cancer. 1989 Aug 1;64(3):730-7 [2743266.001]
  • [Cites] Acta Cytol. 1989 Sep-Oct;33(5):635-8 [2781965.001]
  • [Cites] Cancer Genet Cytogenet. 1989 Oct 15;42(2):187-90 [2790753.001]
  • [Cites] Cancer. 1989 Dec 1;64(11):2319-34 [2804923.001]
  • [Cites] Cancer. 1974 Nov;34(5):1796-805 [4426036.001]
  • [Cites] Arkh Patol. 1969;31(10):14-24 [5393870.001]
  • [Cites] Pathol Res Pract. 1979 Dec;166(1):112-22 [551397.001]
  • [Cites] J Bone Joint Surg Am. 2000 Aug;82-A(8):1122-31 [10954102.001]
  • [Cites] Pathol Int. 2000 Oct;50(10):801-7 [11107052.001]
  • [Cites] J Bone Joint Surg Am. 1975 Mar;57(2):148-54 [1112840.001]
  • [Cites] J Mol Diagn. 2001 Feb;3(1):16-21 [11227067.001]
  • [Cites] J Pathol. 2001 Sep;195(2):218-21 [11592101.001]
  • [Cites] Radiographics. 2003 Jan-Feb;23(1):157-77 [12533651.001]
  • [Cites] Clin Orthop Relat Res. 2003 Mar;(408):256-61 [12616068.001]
  • [Cites] Med Pediatr Oncol. 2003 May;40(5):276-87 [12652615.001]
  • [Cites] Skeletal Radiol. 1992;21(8):493-502 [1281557.001]
  • [Cites] J Clin Oncol. 2003 Aug 15;21(16):3072-8 [12915596.001]
  • [Cites] J Pathol Bacteriol. 1954 Jan;67(1):163-8 [13152629.001]
  • [Cites] J Bone Joint Surg Am. 1954 Jul;36-A(4):704-20 [13174600.001]
  • [Cites] Cancer. 1957 May-Jun;10(3):540-59 [13460949.001]
  • [Cites] J Cancer Res Clin Oncol. 1992;118(2):152-6 [1370955.001]
  • [Cites] Acta radiol. 1960 May;53:377-84 [13816680.001]
  • [Cites] J Bone Joint Surg Am. 1964 Jan;46:151-8 [14104305.001]
  • [Cites] Acta Cytol. 1992 Nov-Dec;36(6):951-6 [1449035.001]
  • [Cites] Am J Surg Pathol. 2003 Dec;27(12):1530-7 [14657712.001]
  • [Cites] Hum Pathol. 2004 Jan;35(1):69-74 [14745727.001]
  • [Cites] Ann R Coll Surg Engl. 1951 May;8(5):329-53 [14830121.001]
  • [Cites] Skeletal Radiol. 2004 Aug;33(8):488-92 [14999433.001]
  • [Cites] AJR Am J Roentgenol. 2004 Dec;183(6):1737-44 [15547221.001]
  • [Cites] Am J Surg Pathol. 1992 Mar;16(3):282-90 [1599019.001]
  • [Cites] Am J Surg Pathol. 2005 Aug;29(8):1025-33 [16006796.001]
  • [Cites] Chest. 1991 Jul;100(1):279-81 [1647939.001]
  • [Cites] Arkh Patol. 2006 Jan-Feb;68(1):14-8 [16544529.001]
  • [Cites] Onkologie. 2006 Jun;29(6):276-8 [16783903.001]
  • [Cites] Clin Orthop Relat Res. 2006 Jul;448:259-66 [16826129.001]
  • [Cites] Histopathology. 1978 May;2(3):189-200 [566709.001]
  • [Cites] J Bone Joint Surg Br. 1966 Feb;48(1):138-44 [5909059.001]
  • [Cites] Radiology. 1967 Oct;89(4):747-52 [6059620.001]
  • [Cites] Am J Surg Pathol. 1982 Jul;6(5):427-34 [6181697.001]
  • [Cites] Arch Pathol Lab Med. 1983 Sep;107(9):500-1 [6688344.001]
  • [Cites] Skeletal Radiol. 1983;10(1):61-6 [6879221.001]
  • [Cites] J Cancer Res Clin Oncol. 1982;104(3):315-20 [7161313.001]
  • [Cites] Am J Surg Pathol. 1982 Mar;6(2):159-63 [7201749.001]
  • [Cites] Am J Pathol. 1995 Dec;147(6):1770-9 [7495301.001]
  • [Cites] Pathol Res Pract. 1995 Mar;191(2):112-20 [7567680.001]
  • [Cites] Am J Surg Pathol. 1993 Dec;17(12):1225-33 [7694513.001]
  • [Cites] Diagn Cytopathol. 1994;10(4):347-51 [7924808.001]
  • [Cites] J Bone Joint Surg Am. 1994 Oct;76(10):1482-99 [7929496.001]
  • [Cites] Intern Med. 1994 Jul;33(7):441-5 [7949646.001]
  • [Cites] Clin Orthop Relat Res. 1994 Dec;(309):234-44 [7994967.001]
  • [Cites] J Clin Oncol. 1993 Aug;11(8):1482-8 [8101562.001]
  • [Cites] Cancer. 1994 Mar 15;73(6):1746-52 [8156503.001]
  • [Cites] Hum Pathol. 1977 Mar;8(2):141-53 [852865.001]
  • [Cites] Acta Cytol. 1988 Jul-Aug;32(4):579-81 [3041724.001]
  • [Cites] Orthopedics. 1988 Nov;11(11):1565-6 [3200767.001]
  • [Cites] Clin Orthop Relat Res. 1986 Mar;(204):215-37 [3514033.001]
  • [Cites] Am J Clin Pathol. 1985 Jan;83(1):108-14 [3966430.001]
  • [Cites] J Bone Joint Surg Am. 1979 Jun;61(4):599-600 [438250.001]
  • (PMID = 18279517.001).
  • [ISSN] 1746-1596
  • [Journal-full-title] Diagnostic pathology
  • [ISO-abbreviation] Diagn Pathol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2276480
  •  go-up   go-down


Advertisement
4. Hatori M, Watanabe M, Hosaka M, Sasano H, Narita M, Kokubun S: A classic adamantinoma arising from osteofibrous dysplasia-like adamantinoma in the lower leg: a case report and review of the literature. Tohoku J Exp Med; 2006 May;209(1):53-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A classic adamantinoma arising from osteofibrous dysplasia-like adamantinoma in the lower leg: a case report and review of the literature.
  • Adamantinoma is known as a low-grade malignant biphasic tumor.
  • Classic adamantinoma is in general characterized by admixture of both epithelial and osteofibrous components that are associated with various proportions and differentiation patterns.
  • OFD-like adamantinoma is characterized by predominance of osteofibrous tissues, in which small groups of epithelial cells are only detected by careful search or immunohistochemistry.
  • There have been controversies as to the potential correlation among OFD, OFD-like adamantinoma and classic adamantinoma.
  • We report an unusual case of adamantinoma arising in the tibia, with an extensive review of the literature.
  • The present findings suggest a direct correlation between OFD-like adamantinoma and classic adamantinoma.
  • The biopsy lesion was diagnosed as classic adamantinoma.
  • The primary lesion was retrospectively diagnosed as OFD-like adamantinoma because of presence of keratin-positive epithelial cells within the stroma.
  • The retrospective histological findings of OFD-like adamantinoma in the original biopsy and of a classic adamantinoma in all sections of the later resection specimen raised the possibility of an unusual progression of OFD-like adamantinoma to a classic adamantinoma.
  • The present case and the literature review suggest that an OFD-like adamantinoma may be a precursor lesion of classic adamantinoma.
  • Therefore, the possibility of progression of OFD-like adamantinoma to a classic adamantinoma should be kept in mind, particularly when the destructive changes are seen radiologically.
  • [MeSH-major] Adamantinoma / physiopathology. Bone Diseases, Developmental / physiopathology. Leg

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16636523.001).
  • [ISSN] 0040-8727
  • [Journal-full-title] The Tohoku journal of experimental medicine
  • [ISO-abbreviation] Tohoku J. Exp. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Japan
  • [Number-of-references] 19
  •  go-up   go-down


5. Namba Y, Kimata Y, Koshima I, Sugihara S, Sato T: Fibular osteoadiposal flap for treatment of tibial adamantinoma: a case report. Acta Med Okayama; 2006 Aug;60(4):233-6
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fibular osteoadiposal flap for treatment of tibial adamantinoma: a case report.
  • We treated a case with left tibial adamantinoma by use of a contralateral fibular osteoadiposal flap.
  • [MeSH-major] Adamantinoma / surgery. Bone Neoplasms / surgery. Fibula / surgery. Skin Transplantation. Surgical Flaps. Tibia / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16943861.001).
  • [ISSN] 0386-300X
  • [Journal-full-title] Acta medica Okayama
  • [ISO-abbreviation] Acta Med. Okayama
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


6. Hahn SB, Kim SH, Cho NH, Choi CJ, Kim BS, Kang HJ: Treatment of osteofibrous dysplasia and associated lesions. Yonsei Med J; 2007 Jun 30;48(3):502-10

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: To report long term treatment outcomes of osteofibrous dysplasia and association with adamantinoma.
  • After the initial pathology slides of the 13 patients were reviewed with immunohistochemical cytokeratin staining, one patient diagnosis was changed from osteofibrous dysplasia to osteofibrous dysplasia-like adamantinoma.
  • CONCLUSION: Some patients with osteofibrous dysplasia require close observation because of the high association risk between osteofibrous dysplasia and adamantinoma, Immunohistochemical staining may be helpful in differentiating these two diagnoses.
  • [MeSH-major] Adamantinoma / surgery. Fibrous Dysplasia of Bone / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Bone Joint Surg Am. 1981 Mar;63(3):483-8 [7204453.001]
  • [Cites] J Bone Joint Surg Br. 2006 May;88(5):658-64 [16645116.001]
  • [Cites] J Bone Joint Surg Am. 2000 Aug;82-A(8):1122-31 [10954102.001]
  • [Cites] Skeletal Radiol. 2003 May;32(5):245-58 [12679847.001]
  • [Cites] Am J Orthop (Belle Mead NJ). 2003 Oct;32(10):479-86 [14620087.001]
  • [Cites] Arch Pathol. 1966 Sep;82(3):218-33 [5944441.001]
  • [Cites] Ital J Orthop Traumatol. 1976 Aug;2(2):221-37 [1024109.001]
  • [Cites] Cancer. 1977 May;39(5):2067-72 [404024.001]
  • [Cites] Hum Pathol. 1977 Mar;8(2):141-53 [852865.001]
  • [Cites] Arch Orthop Trauma Surg. 1979 Jul 31;94(2):143-9 [475564.001]
  • [Cites] J Bone Joint Surg Am. 1981 Mar;63(3):367-75 [7204433.001]
  • [Cites] Cancer. 1983 Sep 1;52(5):909-14 [6871831.001]
  • [Cites] Skeletal Radiol. 1988;17(7):483-6 [3201274.001]
  • [Cites] Clin Orthop Relat Res. 1989 Jan;(238):294-301 [2910613.001]
  • [Cites] Cancer. 1989 Dec 1;64(11):2319-34 [2804923.001]
  • [Cites] J Cancer Res Clin Oncol. 1992;118(2):152-6 [1370955.001]
  • [Cites] Am J Surg Pathol. 1992 Mar;16(3):282-90 [1599019.001]
  • [Cites] Hum Pathol. 1993 Dec;24(12):1339-47 [8276381.001]
  • [Cites] Cancer. 1994 Mar 15;73(6):1746-52 [8156503.001]
  • [Cites] J Bone Joint Surg Am. 1994 Oct;76(10):1482-99 [7929496.001]
  • [Cites] Histopathology. 1994 Jul;25(1):71-6 [7525449.001]
  • [Cites] Clin Orthop Relat Res. 1994 Dec;(309):234-44 [7994967.001]
  • [Cites] Arch Orthop Trauma Surg. 2005 Apr;125(3):177-83 [15723192.001]
  • [Cites] J Bone Joint Surg Am. 1982 Feb;64(2):231-6 [7035460.001]
  • (PMID = 17594160.001).
  • [ISSN] 0513-5796
  • [Journal-full-title] Yonsei medical journal
  • [ISO-abbreviation] Yonsei Med. J.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Chemical-registry-number] 68238-35-7 / Keratins
  • [Other-IDs] NLM/ PMC2628088
  •  go-up   go-down


7. Dini LI, Mendonça R, Adamy CA, Saraiva GA: Adamantinoma of the Spine: Case Report. Neurosurgery; 2006 Aug 01;59(2):E426

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adamantinoma of the Spine: Case Report.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28180646.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


8. Kitsoulis P, Charchanti A, Paraskevas G, Marini A, Karatzias G: Adamantinoma. Acta Orthop Belg; 2007 Aug;73(4):425-31
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adamantinoma.
  • Adamantinoma is one of the rarest low-grade malignant bone tumours, representing less than 1% of them.
  • Fisher in 1913 named this tumour adamantinoma because of its similarity to ameloblastoma of the jaw.
  • Young males are more prone to develop adamantinoma than females.
  • [MeSH-major] Adamantinoma. Bone Neoplasms

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17939469.001).
  • [ISSN] 0001-6462
  • [Journal-full-title] Acta orthopaedica Belgica
  • [ISO-abbreviation] Acta Orthop Belg
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Belgium
  • [Number-of-references] 58
  •  go-up   go-down


9. A J, Kc BR, Basnet SB, Panth R, Shrestha RL, Chand P, Thapa BB: Adamantinoma of tibial shaft. JNMA J Nepal Med Assoc; 2009 Oct-Dec;48(176):331-4
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adamantinoma of tibial shaft.
  • Adamantinoma is an extremely rare primary bony neoplasm.
  • On the other hand adamantinoma mimics many benign conditions, so it is doubly important to establish correct tissue diagnosis to avoid radical surgery with morbidities.
  • Because of its rarity, diagnosing adamantinoma still remains difficult, even if when it occurs in classical sites.
  • We report a case of adamantinoma of tibial shaft diaphysis in a 23 year male.
  • In this case, because of classic clinic-radiological features, we were suspecting adamantinoma from very beginning but final diagnosis was delayed for nine months.
  • [MeSH-major] Adamantinoma / diagnosis. Bone Neoplasms / diagnosis. Tibia

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21105562.001).
  • [ISSN] 0028-2715
  • [Journal-full-title] JNMA; journal of the Nepal Medical Association
  • [ISO-abbreviation] JNMA J Nepal Med Assoc
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Nepal
  •  go-up   go-down


10. Most MJ, Sim FH, Inwards CY: Osteofibrous dysplasia and adamantinoma. J Am Acad Orthop Surg; 2010 Jun;18(6):358-66
The Weizmann Institute of Science GeneCards and MalaCards databases. gene/protein/disease-specific - MalaCards for osteofibrous dysplasia .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Osteofibrous dysplasia and adamantinoma.
  • Adamantinoma (AD) is a rare, low-grade malignant primary bone tumor that occurs most often in the tibia and/or fibula of adolescent persons and young adults; however, it has been reported in other long bones, as well.
  • More recently, published reports have described another clinical entity-differentiated or OFD-like AD-that appears to lie between OFD and AD along a spectrum of disease.
  • [MeSH-major] Adamantinoma / pathology. Adamantinoma / surgery. Bone Neoplasms / pathology. Bone Neoplasms / surgery. Fibrous Dysplasia of Bone / pathology. Fibrous Dysplasia of Bone / surgery

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20511441.001).
  • [ISSN] 1067-151X
  • [Journal-full-title] The Journal of the American Academy of Orthopaedic Surgeons
  • [ISO-abbreviation] J Am Acad Orthop Surg
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 46
  •  go-up   go-down


16. Bishop JA, Ali SZ: Primary tibial adamantinoma diagnosed by fine needle aspiration. Diagn Cytopathol; 2010 Mar;38(3):198-201
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary tibial adamantinoma diagnosed by fine needle aspiration.
  • Adamantinoma is one of the rarest primary bone tumors and is almost exclusively found in the tibia.
  • Because of its scarcity, there are only a handful of reported cases of adamantinoma diagnosed by fine needle aspiration (FNA).
  • An immunostain for cytokeratin was positive, supporting the diagnosis of adamantinoma.
  • Due primarily to its rarity, the diagnosis of adamantinoma on FNA can be challenging and must be made in the context of its characteristic clinical and radiographic setting.
  • [MeSH-major] Adamantinoma / diagnosis. Bone Neoplasms / diagnosis. Tibia / pathology
  • [MeSH-minor] Adult. Biomarkers, Tumor / analysis. Biopsy, Fine-Needle. Bone Transplantation. Female. Humans. Immunohistochemistry. Keratins / analysis

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19774617.001).
  • [ISSN] 1097-0339
  • [Journal-full-title] Diagnostic cytopathology
  • [ISO-abbreviation] Diagn. Cytopathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 68238-35-7 / Keratins
  •  go-up   go-down


17. Van Rijn R, Bras J, Schaap G, van den Berg H, Maas M: Adamantinoma in childhood: report of six cases and review of the literature. Pediatr Radiol; 2006 Oct;36(10):1068-74
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adamantinoma in childhood: report of six cases and review of the literature.
  • BACKGROUND: Adamantinoma is a rare slow-growing malignant bone tumour.
  • MATERIALS AND METHODS: The database of the Working Group on Paediatric Oncology, Academic Medical Centre/Emma Children's Hospital Amsterdam, was searched for cases of adamantinoma.
  • Additionally a literature study was performed to identify cases of adamantinoma in childhood.
  • RESULTS: We identified six local cases of adamantinoma of the long bones, two boys (age 3 and 8 years) and four girls (mean age 8.8 years, range 3.0-14.0 years).
  • On follow-up (mean 6.1 years, range 1.6-12.0 years) all children remained disease-free.
  • CONCLUSION: Although the incidence of adamantinoma is low, it is important to recognize this rare bone tumour, since in the early stages of the disease adequate treatment will result in an excellent prognosis.
  • [MeSH-major] Adamantinoma / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg Pathol. 1981 Sep;5(6):533-42 [7325273.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1982;398(1):75-86 [6819703.001]
  • [Cites] Ann Pathol. 1993;13(5):336-40 [8311861.001]
  • [Cites] Rev Chir Orthop Reparatrice Appar Mot. 1995;81(4):333-7 [8560003.001]
  • [Cites] Acta Clin Belg. 1990;45(1):31-3 [2161603.001]
  • [Cites] Am J Roentgenol Radium Ther Nucl Med. 1966 Jul;97(3):727-32 [5927616.001]
  • [Cites] Pathol Res Pract. 1991 Dec;187(8):1039-43; discussion 1043-4 [1724319.001]
  • [Cites] Hum Genet. 1990 Oct;85(5):513-5 [2227936.001]
  • [Cites] Cancer. 1989 Dec 1;64(11):2319-34 [2804923.001]
  • [Cites] Acta Orthop Belg. 2002 Oct;68(4):412-6 [12415948.001]
  • [Cites] Clin Orthop Relat Res. 1989 Jan;(238):294-301 [2910613.001]
  • [Cites] Virchows Arch A Pathol Anat Histol. 1975;365(1):63-74 [804740.001]
  • [Cites] Rofo. 1992 Sep;157(3):239-44 [1391818.001]
  • [Cites] Clin Orthop Relat Res. 1972 Jul-Aug;86:178-82 [5047786.001]
  • [Cites] Indian J Pathol Microbiol. 1980 Oct;23(4):293-8-B [7228218.001]
  • [Cites] Clin Orthop Relat Res. 1984 Nov;(190):299-310 [6207973.001]
  • [Cites] Cancer. 1989 Aug 1;64(3):730-7 [2743266.001]
  • [Cites] Cancer Genet Cytogenet. 1997 Aug;97(1):5-11 [9242211.001]
  • [Cites] Skeletal Radiol. 1988;17(7):522-6 [3201280.001]
  • [Cites] Clin Nucl Med. 2000 Dec;25(12 ):1057-8 [11129155.001]
  • [Cites] Vrach Delo. 1990 Jun;(6):96-8 [2399736.001]
  • [Cites] Int Orthop. 1994;18(6):379-88 [7698872.001]
  • [Cites] Pathologica. 1984 May-Jun;76(1043):313-22 [6493828.001]
  • [Cites] Arch Putti Chir Organi Mov. 1977;28:129-35 [931601.001]
  • [Cites] AJR Am J Roentgenol. 2004 Dec;183(6):1737-44 [15547221.001]
  • [Cites] J Belge Radiol. 1993 Jun;76(3):154-6 [8253651.001]
  • [Cites] Acta Cytol. 1988 Jul-Aug;32(4):579-81 [3041724.001]
  • [Cites] J Mol Diagn. 2001 Feb;3(1):16-21 [11227067.001]
  • [Cites] Johns Hopkins Med J. 1979 Sep;145(3):107-11 [381755.001]
  • [Cites] Unfallchirurgie. 1990 Feb;16(1):47-9 [2316056.001]
  • [Cites] Am J Clin Pathol. 1984 Oct;82(4):470-4 [6475846.001]
  • [Cites] Chest. 1991 Jul;100(1):279-81 [1647939.001]
  • [Cites] Int Orthop. 1986;10(4):253-9 [3804526.001]
  • [Cites] Acta Radiol. 1998 May;39(3):276-8 [9571943.001]
  • [Cites] J Bone Joint Surg Am. 1986 Jun;68(5):772-6 [3722237.001]
  • [Cites] Cancer Genet Cytogenet. 1989 Oct 15;42(2):187-90 [2790753.001]
  • [Cites] J Bone Joint Surg Am. 1987 Oct;69(8):1177-88 [3312206.001]
  • [Cites] Cancer. 1957 May-Jun;10(3):540-59 [13460949.001]
  • [Cites] Foot Ankle Int. 1997 Nov;18(11):746-51 [9391822.001]
  • [Cites] Cancer. 1985 Mar 1;55(5):1015-23 [2578304.001]
  • [Cites] Ugeskr Laeger. 1984 Aug 6;146(32):2401-3 [6515843.001]
  • [Cites] J Cancer Res Clin Oncol. 1982;104(3):315-20 [7161313.001]
  • [Cites] Histopathology. 1994 Jul;25(1):71-6 [7525449.001]
  • [Cites] Clin Orthop Relat Res. 1965 Nov-Dec;43:189-213 [5861090.001]
  • [Cites] Skeletal Radiol. 1992;21(8):493-502 [1281557.001]
  • [Cites] Chirurg. 1984 Jun;55(6):407-10 [6468037.001]
  • [Cites] Orthopedics. 1988 Nov;11(11):1565-6 [3200767.001]
  • [Cites] J Bone Joint Surg Am. 1994 Oct;76(10):1482-99 [7929496.001]
  • [Cites] Skeletal Radiol. 1990;19(1):55-8 [2326657.001]
  • [Cites] Skeletal Radiol. 1998 Jul;27(7):406-9 [9730336.001]
  • [Cites] Clin Orthop Relat Res. 1986 Mar;(204):215-37 [3514033.001]
  • (PMID = 16906392.001).
  • [ISSN] 0301-0449
  • [Journal-full-title] Pediatric radiology
  • [ISO-abbreviation] Pediatr Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 59
  •  go-up   go-down


18. Chandrasekar CR, Mohammed R, Rafalla AA, Grimer RJ: Adamantinoma of the calcaneum--a case report. Foot (Edinb); 2009 Mar;19(1):58-61
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adamantinoma of the calcaneum--a case report.
  • Adamantinoma is rare, representing less than 1% of all primary malignant bone tumours.
  • Adamantinoma commonly occurs in the tibia.
  • Adamantinoma of the foot is extremely rare.
  • To our knowledge adamantinoma of the calcaneum has not been previously reported in the literature.
  • We report the case of a male patient, aged 33 years, who was treated for adamantinoma of the calcaneum and followed for 16 years highlighting the difficulty in diagnosis and management of this rare tumor occurring at a rare site.
  • [MeSH-major] Adamantinoma / pathology. Bone Neoplasms / pathology. Calcaneus / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20307451.001).
  • [ISSN] 1532-2963
  • [Journal-full-title] Foot (Edinburgh, Scotland)
  • [ISO-abbreviation] Foot (Edinb)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


19. Panchwagh Y, Puri A, Agarwal M, Chinoy R, Jambhekar N: Case report: metastatic adamantinoma of the tibia--an unusual presentation. Skeletal Radiol; 2006 Mar;35(3):190-3
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Case report: metastatic adamantinoma of the tibia--an unusual presentation.
  • A 26-year-old female with a tibial lesion diagnosed as an adamantinoma was treated with intra-lesional curettage, bone grafting and intra-medullary nailing.
  • Although cases of local recurrences and pulmonary metastases in adamantinoma are reported, this case is unusual in presenting without a local recurrence but with simultaneous skeletal and pulmonary metastases.
  • [MeSH-major] Adamantinoma / secondary. Bone Neoplasms / pathology. Femoral Neoplasms / secondary. Lung Neoplasms / secondary. Tibia

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 1989 Aug 1;64(3):730-7 [2743266.001]
  • [Cites] Clin Orthop Relat Res. 1995 Jan;(310):194-9 [7641438.001]
  • [Cites] Presse Med. 1994 Oct 29;23(33):1522-6 [7824479.001]
  • [Cites] J Bone Joint Surg Am. 1994 Oct;76(10):1482-99 [7929496.001]
  • [Cites] Clin Orthop Relat Res. 1986 Mar;(204):215-37 [3514033.001]
  • (PMID = 16402219.001).
  • [ISSN] 0364-2348
  • [Journal-full-title] Skeletal radiology
  • [ISO-abbreviation] Skeletal Radiol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


20. Mathew M, Joseph B: Differentiated adamantinoma: a case report and review of literature. Indian J Pathol Microbiol; 2007 Jul;50(3):565-7
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Differentiated adamantinoma: a case report and review of literature.
  • Adamantinoma of the long bones are uncommon, slow growing tumors with a predilection for the tibia.
  • A special rare variant known as the osteofibrous dysplasia-like adamantinoma or differentiated adamantinoma is thought to be a precursor of the classic adamantinoma.
  • Microscopy showed a tumor composed predominantly of osteofibrous dysplasia-like areas with focal cytokeratin positive epithelial islands.
  • [MeSH-major] Adamantinoma / diagnosis. Bone Neoplasms / diagnosis. Tibia / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17883137.001).
  • [ISSN] 0377-4929
  • [Journal-full-title] Indian journal of pathology & microbiology
  • [ISO-abbreviation] Indian J Pathol Microbiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


21. Mavrogenis AF, Galanakos S, Savvidou OD, Papagelopoulos PJ: Adamantinoma of the tibia mimicking a benign cystic lesion: a case report. Clin Podiatr Med Surg; 2010 Jan;27(1):157-65
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adamantinoma of the tibia mimicking a benign cystic lesion: a case report.
  • Adamantinoma of the long bones is a rare primary malignant bone tumor accounting for less than 1% of all primary malignant bone tumors.
  • In this article, the authors present a case report of a patient with a distal tibia adamantinoma mimicking a benign cystic lesion.
  • [MeSH-major] Adamantinoma / diagnosis. Bone Cysts / diagnosis. Bone Neoplasms / diagnosis. Tibia

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19963177.001).
  • [ISSN] 1558-2302
  • [Journal-full-title] Clinics in podiatric medicine and surgery
  • [ISO-abbreviation] Clin Podiatr Med Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


22. Al-Daraji WI, Al-Daraji UW, Al-Mahmoud RM: Adamantinoma associated with botryomycosis: the first report of this rare association after trauma. Clin Exp Dermatol; 2008 Jul;33(4):433-6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adamantinoma associated with botryomycosis: the first report of this rare association after trauma.
  • We report for the first time to our knowledge a unique case of both botryomycosis and adamantinoma in the right tibia of the same patient at an area of previous trauma.
  • Although both botryomycosis and adamantinoma usually have a history of trauma, as in our patient, a causal relationship will need more cases to establish a possible link.
  • [MeSH-major] Adamantinoma / complications. Granulomatous Disease, Chronic / complications. Staphylococcal Skin Infections / complications. Tibia. Wounds, Nonpenetrating / complications

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18312455.001).
  • [ISSN] 1365-2230
  • [Journal-full-title] Clinical and experimental dermatology
  • [ISO-abbreviation] Clin. Exp. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


23. Desai SS, Jambhekar N, Agarwal M, Puri A, Merchant N: Adamantinoma of tibia: a study of 12 cases. J Surg Oncol; 2006 Apr 1;93(5):429-33
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adamantinoma of tibia: a study of 12 cases.
  • BACKGROUND: Adamantinoma is a rare tumor of long bones that can be mistaken for a carcinoma, and numerous other lesions such as myoepithelial tumor, malignant mixed tumor of bone, fibrous dysplasia/osteofibrous dysplasia, and vascular tumors.
  • Radiologically the tumor presented as a lytic, eccentric, intracortical lesion in the tibia.
  • DISCUSSION: In this article, an attempt is made to study the morphology, biology, and the differential diagnoses of adamantinoma of long bones.
  • [MeSH-major] Adamantinoma. Bone Neoplasms. Tibia

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2006 Wiley-Liss, Inc.
  • (PMID = 16550582.001).
  • [ISSN] 0022-4790
  • [Journal-full-title] Journal of surgical oncology
  • [ISO-abbreviation] J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 30
  •  go-up   go-down


24. Flowers R, Baliga M, Guo M, Liu SS: Tibial adamantinoma with local recurrence and pulmonary metastasis: report of a case with histocytologic findings. Acta Cytol; 2006 Sep-Oct;50(5):567-73
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tibial adamantinoma with local recurrence and pulmonary metastasis: report of a case with histocytologic findings.
  • BACKGROUND: Adamantinoma is a rare primary bone neoplasm of low malignant potential that may recur or metastasize in a mall percentage of patients.
  • The myriad histologic patterns may cause difficulty in distinguishing this tumor from other primary or metastatic neoplasms.
  • CASE: A 32-year-old man presented with a mass in the distal side of the left leg that was diagnosed as classic adamantinoma by open biopsy.
  • CONCLUSION: The diagnosis of adamantinoma requires knowledge of compatible clinical and radiologic studies as well as understanding of the variable histologic patterns that one may encounter.
  • Fine needle aspiration biopsy is particularly useful in the diagnosis of recurrent and metastatic adamantinoma.
  • This case report describes a distinctive cytomorphologic feature of nuclear grooves that may be a useful aid in distinguishing the tumor cells of adamantinoma from other cell types.
  • [MeSH-major] Adamantinoma / diagnosis. Bone Neoplasms / diagnosis. Lung / pathology. Lung Neoplasms / diagnosis. Neoplasm Recurrence, Local / diagnosis. Tibia / pathology
  • [MeSH-minor] Adult. Amputation. Biomarkers, Tumor / analysis. Biomarkers, Tumor / biosynthesis. Biopsy, Fine-Needle. Cell Shape. Diagnosis, Differential. Disease Progression. Epithelial Cells / pathology. Humans. Magnetic Resonance Imaging. Male. Nuclear Envelope / pathology. Prognosis

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17017449.001).
  • [ISSN] 0001-5547
  • [Journal-full-title] Acta cytologica
  • [ISO-abbreviation] Acta Cytol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


25. Izquierdo FM, Ramos LR, Sánchez-Herráez S, Hernández T, de Alava E, Hazelbag HM: Dedifferentiated classic adamantinoma of the tibia: a report of a case with eventual complete revertant mesenchymal phenotype. Am J Surg Pathol; 2010 Sep;34(9):1388-92
MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Dedifferentiated classic adamantinoma of the tibia: a report of a case with eventual complete revertant mesenchymal phenotype.
  • We report a case of an adamantinoma with a revertant sarcomatoid transformation that showed a complete loss of epithelial differentiation.
  • On the en bloc resection specimen, areas of classic adamantinoma were found but most of the tumor corresponded to a high-grade neoplasm with 2 histologic patterns: one made up by epithelial nests with a basaloid arrangement and positive for pankeratins and so-called glandular keratins, and a second sarcomatoid component, negative for these epithelial markers.
  • However, our case represents the extreme end of the sarcomatoid dedifferentiation of a classic adamantinoma with complete sarcomatoid transformation and total loss of epithelial markers.
  • [MeSH-major] Adamantinoma / pathology. Bone Neoplasms / pathology. Sarcoma / pathology. Tibia / pathology
  • [MeSH-minor] Adult. Biomarkers / metabolism. Biomarkers, Tumor / metabolism. Cell Transformation, Neoplastic. Humans. Keratins / metabolism. Male. Mesoderm / pathology. Neoplasms, Second Primary. Phenotype. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20717000.001).
  • [ISSN] 1532-0979
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers; 0 / Biomarkers, Tumor; 0 / CAM 5.2 antigen; 68238-35-7 / Keratins
  •  go-up   go-down


26. Frey SP, Hardes J, Ahrens H, Winkelmann W, Gosheger G: Total tibia replacement using an allograft (in a patient with adamantinoma). Case report and review of literature. J Cancer Res Clin Oncol; 2008 Apr;134(4):427-31

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Total tibia replacement using an allograft (in a patient with adamantinoma). Case report and review of literature.
  • INTRODUCTION: Adamantinoma is a very rare, low-grade, malignant bone tumour that accounts for approximately 0.4% of all primary bone tumours.
  • CASE PRESENTATION: We present a case of adamantinoma of the tibia, in which a resection of the whole tibia and reconstruction with a total tibia allograft was necessary.
  • It is often difficult to distinguish an adamantinoma from other tumours.
  • The most frequent described method to treat adamantinoma is wide resection and the use of an allograft.
  • [MeSH-major] Adamantinoma / surgery. Tibia / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] N Engl J Med. 1976 Jun 3;294(23):1247-55 [772430.001]
  • [Cites] Acta Orthop. 2005 Dec;76(6):944-6 [16470458.001]
  • [Cites] J Bone Joint Surg Am. 1966 Jul;48(5):968-90 [5328989.001]
  • [Cites] J Bone Joint Surg Am. 2000 Aug;82-A(8):1122-31 [10954102.001]
  • [Cites] J Bone Joint Surg Am. 1980 Sep;62(6):1027-30 [7000786.001]
  • [Cites] Clin Orthop Relat Res. 1972 Sep;87:156-64 [4562186.001]
  • [Cites] Clin Orthop Relat Res. 2001 Jan;(382):66-74 [11154007.001]
  • [Cites] Clin Orthop Relat Res. 1996 Mar;(324):86-97 [8595781.001]
  • [Cites] J Bone Joint Surg Am. 1990 Jul;72 (6):825-33 [2365716.001]
  • [Cites] J Bone Joint Surg Br. 1970 Feb;52(1):49-53 [4314242.001]
  • (PMID = 18060426.001).
  • [ISSN] 0171-5216
  • [Journal-full-title] Journal of cancer research and clinical oncology
  • [ISO-abbreviation] J. Cancer Res. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 16
  •  go-up   go-down


27. Szendroi M, Antal I, Arató G: Adamantinoma of long bones: a long-term follow-up study of 11 cases. Pathol Oncol Res; 2009 Jun;15(2):209-16
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adamantinoma of long bones: a long-term follow-up study of 11 cases.
  • The aim of this study was to evaluate the clinicopathological features and prognostic significances of 11 histologically proven adamantinoma cases based on an average 12,7 year long follow-up.
  • The initial diagnosis at referral was other than adamantinoma in six patients (fibrous dysplasia, carcinoma metastasis, osteofibrous dysplasia, bone cyst, non-ossifying fibroma), referring to the differential diagnostic problems.
  • All adamantinoma were positive for cytokeratins often in coexpression with vimentin.
  • Intralesional curettage (2 pts) was followed by recurrence of the tumor.
  • One patient died 9 years after recognition of the tumor of pulmonary metastases.
  • Adamantinoma of the long bones is a low grade malignant tumor, which clinical outcome is difficult to predict based on histology or surgical stage of the tumor.
  • Wide surgical margin, e.g. resection the tumor reduces the rate of recurrence.
  • This study underlines that recurrences do occur even decades after recognition the tumor, therefore a life-long follow-up of the patient is necessary.
  • [MeSH-major] Adamantinoma / pathology. Bone Neoplasms / pathology. Tibia

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Orthopedics. 2007 Mar;30(3):211-5; quiz 216-7 [17375547.001]
  • [Cites] J Bone Joint Surg Am. 1975 Mar;57(2):148-54 [1112840.001]
  • [Cites] J Bone Joint Surg Br. 2002 Sep;84(7):1009-14 [12358363.001]
  • [Cites] Magy Traumatol Orthop Helyreallito Seb. 1982;25(1):75-9 [6121955.001]
  • [Cites] Cancer. 1989 Dec 1;64(11):2319-34 [2804923.001]
  • [Cites] Pathol Res Pract. 1995 Mar;191(2):112-20 [7567680.001]
  • [Cites] J Bone Joint Surg Am. 2000 Aug;82-A(8):1122-31 [10954102.001]
  • [Cites] Orthopedics. 1983 Apr 1;6(4):472-7 [24823160.001]
  • [Cites] Rofo. 1992 Sep;157(3):239-44 [1391818.001]
  • [Cites] Hum Pathol. 2004 Jan;35(1):69-74 [14745727.001]
  • [Cites] Hum Pathol. 1998 Aug;29(8):809-14 [9712421.001]
  • [Cites] Clin Orthop Relat Res. 1984 Nov;(190):299-310 [6207973.001]
  • [Cites] J Pathol. 1998 Jan;184(1):24-30 [9582523.001]
  • [Cites] J Bone Joint Surg Am. 1954 Jul;36-A(4):704-20 [13174600.001]
  • [Cites] Cancer. 1989 Aug 1;64(3):730-7 [2743266.001]
  • [Cites] J Clin Pathol. 1982 Jul;35(7):780-6 [7201477.001]
  • [Cites] Cancer Genet Cytogenet. 1997 Aug;97(1):5-11 [9242211.001]
  • [Cites] Int Orthop. 1994;18(6):379-88 [7698872.001]
  • [Cites] Tohoku J Exp Med. 2006 May;209(1):53-9 [16636523.001]
  • [Cites] AJR Am J Roentgenol. 2004 Dec;183(6):1737-44 [15547221.001]
  • [Cites] Virchows Arch A Pathol Anat Histol. 1981;393(2):233-44 [6270877.001]
  • [Cites] Ann Surg. 1905 Feb;41(2):249-51 [17861599.001]
  • [Cites] Skeletal Radiol. 2003 May;32(5):245-58 [12679847.001]
  • [Cites] J Bone Joint Surg Am. 1997 Jan;79(1):97-106 [9010190.001]
  • [Cites] J Bone Joint Surg Am. 1987 Oct;69(8):1177-88 [3312206.001]
  • [Cites] Magy Traumatol Ortop Kezseb Plasztikai Seb. 1994;37(1):37-44 [8162138.001]
  • [Cites] J Bone Joint Surg Am. 1994 Oct;76(10):1482-99 [7929496.001]
  • [Cites] Onkologie. 2006 Jun;29(6):276-8 [16783903.001]
  • [Cites] J Pathol Bacteriol. 1954 Jan;67(1):151-61 [13152628.001]
  • [Cites] Clin Orthop Relat Res. 1986 Mar;(204):215-37 [3514033.001]
  • (PMID = 19048403.001).
  • [ISSN] 1219-4956
  • [Journal-full-title] Pathology oncology research : POR
  • [ISO-abbreviation] Pathol. Oncol. Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


28. Khanna M, Delaney D, Tirabosco R, Saifuddin A: Osteofibrous dysplasia, osteofibrous dysplasia-like adamantinoma and adamantinoma: correlation of radiological imaging features with surgical histology and assessment of the use of radiology in contributing to needle biopsy diagnosis. Skeletal Radiol; 2008 Dec;37(12):1077-84

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Osteofibrous dysplasia, osteofibrous dysplasia-like adamantinoma and adamantinoma: correlation of radiological imaging features with surgical histology and assessment of the use of radiology in contributing to needle biopsy diagnosis.
  • OBJECTIVES: The aim of this study was to correlate the imaging features with surgical histology for tibial osteofibrous dysplasia (OFD), osteofibrous dysplasia-like adamantinoma (OFD/LA) and classical adamantinoma and to determine the additional role of imaging in suggesting a correct diagnosis in cases of needle biopsy misdiagnosis.
  • RESULTS: The 24 cases comprised five OFD, 11 OFD/LA and eight adamantinoma based on surgical resection histology.
  • The mean length of OFD was 6.1 cm (range 2-8.5 cm), for OFD/LA was 6.5 cm (range 2-13 cm) and for adamantinoma was 13.2 cm (range 6.5-26 cm).
  • Four of 19 cases had a different needle biopsy result compared to the final histology, three cases being upgraded from an OFD/LA or OFD to classical adamantinoma.
  • The radiological features of these three cases were more in keeping with a diagnosis of adamantinoma.
  • CONCLUSIONS: A diagnosis of classical adamantinoma is suggested by an extensive lesion with moth-eaten margins and complete involvement of the medullary cavity on axial MR imaging.
  • [MeSH-major] Adamantinoma / diagnosis. Adamantinoma / surgery. Fibrous Dysplasia of Bone / diagnosis. Fibrous Dysplasia of Bone / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Orthop Relat Res. 1992 May;(278):235-43 [1563159.001]
  • [Cites] Acta Clin Belg. 1990;45(1):31-3 [2161603.001]
  • [Cites] J Bone Joint Surg Am. 2000 Aug;82-A(8):1122-31 [10954102.001]
  • [Cites] Arch Pediatr Adolesc Med. 1997 Apr;151(4):427-8 [9111446.001]
  • [Cites] AJR Am J Roentgenol. 1991 May;156(5):1017-23 [2017924.001]
  • [Cites] Hum Pathol. 1993 Dec;24(12 ):1339-47 [8276381.001]
  • [Cites] Rofo. 1992 Sep;157(3):239-44 [1391818.001]
  • [Cites] Cancer. 1989 Aug 1;64(3):730-7 [2743266.001]
  • [Cites] J Bone Joint Surg Am. 1981 Mar;63(3):367-75 [7204433.001]
  • [Cites] J Bone Joint Surg Br. 2006 May;88(5):658-64 [16645116.001]
  • [Cites] AJR Am J Roentgenol. 2004 Dec;183(6):1737-44 [15547221.001]
  • [Cites] Skeletal Radiol. 2003 May;32(5):245-58 [12679847.001]
  • [Cites] J Bone Joint Surg Am. 1994 Oct;76(10):1482-99 [7929496.001]
  • [Cites] Clin Orthop Relat Res. 1986 Mar;(204):215-37 [3514033.001]
  • (PMID = 18690429.001).
  • [ISSN] 0364-2348
  • [Journal-full-title] Skeletal radiology
  • [ISO-abbreviation] Skeletal Radiol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


29. Fujii H, Honoki K, Enomoto Y, Kasai T, Kido A, Amano I, Kumamoto M, Morishita T, Mii Y, Nonomura A, Takakura Y: Adamantinoma-like Ewing's sarcoma with EWS-FLI1 fusion gene: a case report. Virchows Arch; 2006 Nov;449(5):579-84
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adamantinoma-like Ewing's sarcoma with EWS-FLI1 fusion gene: a case report.
  • Recent studies have advocated the genotypic and phenotypic delineation of a novel Ewing's sarcoma histologic variant showing epithelial features defined as "adamantinoma-like Ewing's sarcoma".
  • The diagnosis of the lesion was confirmed as Ewing's sarcoma by the presence of the EWS-FLI1 fusion transcript, and could be defined as the so-called "adamantinoma-like Ewing's sarcoma".
  • [MeSH-major] Adamantinoma / pathology. Bone Neoplasms / pathology. Oncogene Proteins, Fusion / genetics. Proto-Oncogene Protein c-fli-1 / genetics. Sarcoma, Ewing / pathology

  • Genetic Alliance. consumer health - Ewing's Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Pathol Res Pract. 1979 Dec;166(1):112-22 [551397.001]
  • [Cites] C R Seances Acad Sci III. 1983;296(23):1105-7 [6416623.001]
  • [Cites] Am J Surg Pathol. 1981 Sep;5(6):533-42 [7325273.001]
  • [Cites] Med Pediatr Oncol. 2003 May;40(5):276-87 [12652615.001]
  • [Cites] Am J Surg Pathol. 2005 Aug;29(8):1025-33 [16006796.001]
  • [Cites] CA Cancer J Clin. 1972 Mar-Apr;22(2):95-8 [4622125.001]
  • [Cites] Am J Surg Pathol. 1993 Dec;17(12):1225-33 [7694513.001]
  • [Cites] Genes Chromosomes Cancer. 1992 Nov;5(4):271-7 [1283315.001]
  • [Cites] Skeletal Radiol. 1994 Oct;23(7):501-7 [7824975.001]
  • [Cites] Cancer Genet Cytogenet. 1984 May;12(1):1-19 [6713356.001]
  • [Cites] Skeletal Radiol. 1992;21(3):205-9 [1604351.001]
  • [Cites] Cancer. 1992 Feb 1;69(3):698-708 [1730120.001]
  • [Cites] J Clin Oncol. 1993 Oct;11(10):1911-8 [8410118.001]
  • [Cites] Am J Surg Pathol. 2003 Dec;27(12):1530-7 [14657712.001]
  • [Cites] Virchows Arch A Pathol Anat Histol. 1975;365(1):63-74 [804740.001]
  • [Cites] J Clin Oncol. 1993 Aug;11(8):1482-8 [8101562.001]
  • [Cites] Skeletal Radiol. 1983;10 (1):61-6 [6879221.001]
  • [Cites] Am J Surg Pathol. 2000 Mar;24(3):410-6 [10716155.001]
  • [Cites] J Pathol. 2001 Sep;195(2):218-21 [11592101.001]
  • [Cites] Am J Surg Pathol. 1999 Feb;23 (2):159-65 [9989842.001]
  • [Cites] Cancer Res. 2005 Dec 15;65(24):11459-68 [16357154.001]
  • [Cites] Am J Pathol. 1991 Aug;139(2):317-25 [1867320.001]
  • [Cites] Clin Orthop Relat Res. 1993 Jan;(286):241-6 [8425352.001]
  • [Cites] J Clin Oncol. 2003 Aug 15;21(16):3072-8 [12915596.001]
  • [Cites] Am J Pathol. 1987 May;127(2):288-304 [2437802.001]
  • [Cites] J Bone Joint Surg Am. 1994 Oct;76(10):1482-99 [7929496.001]
  • [Cites] Clin Orthop Relat Res. 1986 Mar;(204):215-37 [3514033.001]
  • (PMID = 17016721.001).
  • [ISSN] 0945-6317
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / EWS-FLI fusion protein; 0 / Oncogene Proteins, Fusion; 0 / Proto-Oncogene Protein c-fli-1; 0 / RNA-Binding Protein EWS
  •  go-up   go-down


30. Piña-Oviedo S, Del Valle L, Padilla-Longoria R, Mendoza-Ramón H, Ortiz-Hidalgo C: Primary adamantinoma of the rib. Unusual presentation for a bone neoplasm of uncertain origin. Pathol Oncol Res; 2008 Dec;14(4):497-502
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary adamantinoma of the rib. Unusual presentation for a bone neoplasm of uncertain origin.
  • Although cases of adamantinoma located to the axial skeleton have been reported either as recurrent or metastatic disease, only two cases of primary adamantinoma located to the thoracic wall have been previously described.
  • In this study we present the clinical, radiological and histopathological features of a 24-year-old male with a slow growing, solid-cystic, painful mass, located to the right 11th rib, which was morphological and immunohistochemically diagnosed as a primary classic adamantinoma.
  • [MeSH-major] Adamantinoma / pathology. Ribs / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg Pathol. 1993 Dec;17(12):1225-33 [7694513.001]
  • [Cites] Cancer. 1989 Dec 1;64(11):2319-34 [2804923.001]
  • [Cites] Histopathology. 2000 Jul;37(1):27-32 [10931215.001]
  • [Cites] Intern Med. 1994 Jul;33(7):441-5 [7949646.001]
  • [Cites] J Bone Joint Surg Am. 2000 Aug;82-A(8):1122-31 [10954102.001]
  • [Cites] Rofo. 1992 Sep;157(3):239-44 [1391818.001]
  • [Cites] Hum Pathol. 2004 Jan;35(1):69-74 [14745727.001]
  • [Cites] J Pathol. 1998 Jan;184(1):24-30 [9582523.001]
  • [Cites] J Mol Diagn. 2001 Feb;3(1):16-21 [11227067.001]
  • [Cites] Skeletal Radiol. 2003 May;32(5):245-58 [12679847.001]
  • [Cites] Cancer. 1994 Mar 15;73(6):1746-52 [8156503.001]
  • [Cites] Hum Pathol. 1977 Mar;8(2):141-53 [852865.001]
  • [Cites] Pediatr Dev Pathol. 2003 Mar-Apr;6(2):173-8 [12574919.001]
  • [Cites] South Med J. 1986 Mar;79(3):352-5 [3952546.001]
  • (PMID = 18409022.001).
  • [ISSN] 1219-4956
  • [Journal-full-title] Pathology oncology research : POR
  • [ISO-abbreviation] Pathol. Oncol. Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


31. Mavrogenis AF, Sakellariou VI, Tsibidakis H, Papagelopoulos PJ: Adamantinoma of the tibia treated with a new intramedullary diaphyseal segmental defect implant. J Int Med Res; 2009 Jul-Aug;37(4):1238-45

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adamantinoma of the tibia treated with a new intramedullary diaphyseal segmental defect implant.
  • Histological diagnosis was consistent with adamantinoma, a rare primary bone tumour.
  • [MeSH-major] Adamantinoma / pathology. Adamantinoma / surgery. Limb Salvage / methods. Tibia / pathology. Tibia / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19761710.001).
  • [ISSN] 0300-0605
  • [Journal-full-title] The Journal of international medical research
  • [ISO-abbreviation] J. Int. Med. Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


32. Makhson AN, Bulycheva IV, Kuz'min IV, Pavlenko TV: [Adamantinoma of long tubal bones]. Arkh Patol; 2006 Jan-Feb;68(1):14-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Adamantinoma of long tubal bones].
  • Immunohistochemistry helps in differential diagnosis of this tumor.
  • The surgeons should be warned against enucleation of the tumor.
  • [MeSH-major] Adamantinoma / ultrastructure. Femoral Neoplasms / ultrastructure. Tibia / ultrastructure

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16544529.001).
  • [ISSN] 0004-1955
  • [Journal-full-title] Arkhiv patologii
  • [ISO-abbreviation] Arkh. Patol.
  • [Language] rus
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


33. Łapienis M, Kaczmarczyk D, Zimmer-Nowicka J, Niedźwiecka I, Jesionek-Kupnicka D, Morawiec-Bajda A: [Ameloblastoma of the maxillary sinus--a case report]. Otolaryngol Pol; 2008;62(6):784-6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Ameloblastoma of the maxillary sinus--a case report].
  • [Transliterated title] Szkliwiak zatoki szczekowej--opis przypadku.
  • Ameloblastoma (adamantinoma) is a benign neoplasm deriving from the enamel organ.
  • About 20% of described cases of ameloblastoma relate to the jaw, its very rare location is gingiva or cheak tunica mucosa.
  • The essay presents a case of ameloblastoma of a maxillary sinus in a 65-year-old man.
  • The diagnostic and treatment algorithm in ameloblastoma is discussed.
  • [MeSH-major] Ameloblastoma / pathology. Ameloblastoma / surgery. Maxillary Sinus Neoplasms / pathology. Maxillary Sinus Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19205533.001).
  • [ISSN] 0030-6657
  • [Journal-full-title] Otolaryngologia polska = The Polish otolaryngology
  • [ISO-abbreviation] Otolaryngol Pol
  • [Language] pol
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


34. Farah-Klibi F, Ferchichi L, Beyâa Rassou H, Zairi I, Rameh S, Adouani A, Ben Jilani SB, Zermani R: [Adenomatoid odontogenic tumor: two cases]. Rev Stomatol Chir Maxillofac; 2007 Feb;108(1):61-4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Adenomatoid odontogenic tumor: two cases].
  • INTRODUCTION: Adenomatoid odontogenic tumor, initially referred to as adenoameloblastoma, is a rare and benign odontogenic tumor.
  • CASE REPORTS: We report two cases of adenomatoid odontogenic tumor, which illustrate the radiological and anatomic features of this tumor.
  • DISCUSSION: The clinical, radiological and histological features of adenomatoid odontogenic tumor are distinct from those of ameloblastoma.
  • This tumor is frequently misdiagnosed as other odontogenic cysts or tumors.
  • We discuss the anatomoclinical features and the histogenesis of this rare tumor.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17275864.001).
  • [ISSN] 0035-1768
  • [Journal-full-title] Revue de stomatologie et de chirurgie maxillo-faciale
  • [ISO-abbreviation] Rev Stomatol Chir Maxillofac
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


35. Park YK, Ryu KN, Han CS: Synchronous intracortical adamantinomas with keratin cyst formation. Skeletal Radiol; 2006 Mar;35(3):185-9
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Adamantinoma of the long bones is a rare primary bone tumor of uncertain embryogenesis.
  • This keratin cyst formation is quite an unusual finding in classic adamantinoma.
  • [MeSH-major] Adamantinoma / diagnosis. Bone Cysts / diagnosis. Bone Neoplasms / diagnosis. Fibula / pathology. Keratins / analysis. Magnetic Resonance Imaging. Tibia / pathology

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg Pathol. 1981 Sep;5(6):533-42 [7325273.001]
  • [Cites] J Bone Joint Surg Am. 1975 Mar;57(2):148-54 [1112840.001]
  • [Cites] Am J Surg Pathol. 1993 Dec;17(12):1225-33 [7694513.001]
  • [Cites] Cancer. 1989 Dec 1;64(11):2319-34 [2804923.001]
  • [Cites] Intern Med. 1994 Jul;33(7):441-5 [7949646.001]
  • [Cites] Pathol Res Pract. 1995 Mar;191(2):112-20 [7567680.001]
  • [Cites] Am J Surg Pathol. 2003 Dec;27(12):1530-7 [14657712.001]
  • [Cites] Cancer. 1989 Aug 1;64(3):730-7 [2743266.001]
  • [Cites] J Pathol Bacteriol. 1954 Jan;67(1):163-8 [13152629.001]
  • [Cites] AJR Am J Roentgenol. 2004 Dec;183(6):1737-44 [15547221.001]
  • [Cites] J Pathol. 2001 Sep;195(2):218-21 [11592101.001]
  • [Cites] Skeletal Radiol. 2003 May;32(5):245-58 [12679847.001]
  • [Cites] Cancer. 1957 May-Jun;10(3):540-59 [13460949.001]
  • [Cites] Hum Pathol. 1977 Mar;8(2):141-53 [852865.001]
  • [Cites] Skeletal Radiol. 1992;21(8):493-502 [1281557.001]
  • [Cites] Clin Orthop Relat Res. 1986 Mar;(204):215-37 [3514033.001]
  • (PMID = 16217667.001).
  • [ISSN] 0364-2348
  • [Journal-full-title] Skeletal radiology
  • [ISO-abbreviation] Skeletal Radiol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 68238-35-7 / Keratins
  •  go-up   go-down


36. Motamedi MH, Shafeie HA, Azizi T: Salvage of an impacted canine associated with an adenomatoid odontogenic tumour: a case report. Br Dent J; 2005 Jul 23;199(2):89-90

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The adenomatoid odontogenic tumour (AOT) has been known by a number of descriptive names (adenoameloblastoma, ameloblastic adenomatoid tumour, glandular ameloblastoma, and adenomatoid ameloblastoma) since it was first reported and later recognised as a distinct odontogenic lesion unrelated to ameloblastoma.
  • Although it was considered to be a variant of ameloblastoma at one time leading surgeons to perform unduly aggressive surgery, the treatment outcome experience has borne out the benign, nonaggressive nature of this lesion.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16041334.001).
  • [ISSN] 0007-0610
  • [Journal-full-title] British dental journal
  • [ISO-abbreviation] Br Dent J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


37. Napp M, Stengel BA, Buschmann J, Döhler JR: [Osteofibrous dysplasia campanacci of the tibia. A 12-year follow-up]. Chirurg; 2009 Mar;80(3):241-4
MedlinePlus Health Information. consumer health - Leg Injuries and Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This article concerns a rare tumor-like lesion primarily in the tibial diaphysis in young patients.
  • Despite the controversial indication, we recommend this method due to the disorder's putative relationship with malignant adamantinoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Z Orthop Ihre Grenzgeb. 1993 Jan-Feb;131(1):42-50 [8480439.001]
  • [Cites] Ital J Orthop Traumatol. 1976 Aug;2(2):221-37 [1024109.001]
  • [Cites] Hum Pathol. 1993 Dec;24(12 ):1339-47 [8276381.001]
  • [Cites] J Bone Joint Surg Br. 2007 Aug;89(8):1077-83 [17785749.001]
  • [Cites] Int Orthop. 1992;16(2):180-4 [1428320.001]
  • [Cites] Cancer Genet Cytogenet. 1997 Aug;97(1):5-11 [9242211.001]
  • [Cites] J Bone Joint Surg Br. 2006 May;88(5):658-64 [16645116.001]
  • [Cites] Yonsei Med J. 2007 Jun 30;48(3):502-10 [17594160.001]
  • [Cites] Clin Orthop Relat Res. 1994 Dec;(309):234-44 [7994967.001]
  • [Cites] Acta Orthop Belg. 2007 Aug;73(4):425-31 [17939469.001]
  • (PMID = 18690418.001).
  • [ISSN] 1433-0385
  • [Journal-full-title] Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen
  • [ISO-abbreviation] Chirurg
  • [Language] ger
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


38. Deyrup AT, Montag AG: Epithelioid and epithelial neoplasms of bone. Arch Pathol Lab Med; 2007 Feb;131(2):205-16
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CONTEXT: Epithelioid and epithelial neoplasms seen in bone are rare and include epithelioid variants of vascular lesions, osteoblastoma, osteosarcoma, chordoma, and chondroblastoma as well as adamantinoma and metastatic carcinoma.
  • [MeSH-minor] Biomarkers, Tumor / analysis. Diagnosis, Differential. Humans. Immunohistochemistry. Neoplasm Metastasis / pathology

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17284104.001).
  • [ISSN] 1543-2165
  • [Journal-full-title] Archives of pathology & laboratory medicine
  • [ISO-abbreviation] Arch. Pathol. Lab. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  • [Number-of-references] 86
  •  go-up   go-down


39. Spiegelberg BG, Sewell MD, Coltman T, Blunn GW, Flanagan AM, Cannon SR, Briggs TW: Below-knee amputation through a joint-sparing proximal tibial replacement for recurrent tumour. J Bone Joint Surg Br; 2009 Jun;91(6):815-9
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We report a case which highlights the progression of osteofibrous dysplasia to adamantinoma and questions whether intralesional curettage is the appropriate treatment.
  • [MeSH-major] Adamantinoma / surgery. Amputation / methods. Bone Diseases, Developmental / surgery. Bone Neoplasms / surgery. Neoplasm Recurrence, Local / surgery
  • [MeSH-minor] Adult. Diagnosis, Differential. Disease Progression. Female. Humans. Pain / surgery. Skiing / injuries. Tibial Fractures / complications

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] J Bone Joint Surg Br. 2009 Aug;91(8):1120. Speigelberg, B G I [corrected to Spiegelberg B G I]
  • (PMID = 19483239.001).
  • [ISSN] 0301-620X
  • [Journal-full-title] The Journal of bone and joint surgery. British volume
  • [ISO-abbreviation] J Bone Joint Surg Br
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


40. Lee RS, Weitzel S, Eastwood DM, Monsell F, Pringle J, Cannon SR, Briggs TW: Osteofibrous dysplasia of the tibia. Is there a need for a radical surgical approach? J Bone Joint Surg Br; 2006 May;88(5):658-64
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The possible link with adamantinoma is controversial and some authors believe that they are part of one histological process.
  • There were three confirmed cases of adamantinoma.
  • [MeSH-minor] Adamantinoma / pathology. Adamantinoma / radiography. Adamantinoma / surgery. Adolescent. Adult. Child. Child, Preschool. Curettage / methods. Diagnosis, Differential. Female. Fibula / transplantation. Humans. Male. Orthopedic Procedures / methods. Recurrence. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Bone Joint Surg Br. 2007 Jan;89(1):141 [17259434.001]
  • (PMID = 16645116.001).
  • [ISSN] 0301-620X
  • [Journal-full-title] The Journal of bone and joint surgery. British volume
  • [ISO-abbreviation] J Bone Joint Surg Br
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


41. Folpe AL, Goldblum JR, Rubin BP, Shehata BM, Liu W, Dei Tos AP, Weiss SW: Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases. Am J Surg Pathol; 2005 Aug;29(8):1025-33
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases.
  • More than 85% of Ewing sarcoma/primitive neuroectodermal tumor (ES/PNET), or "Ewing family of tumors" (EFTs), have the translocation, t (11;22) (q24;q12), with others having variant translocations.
  • We therefore studied a large group of genetically confirmed EFTs to more completely understand the morphologic and immunophenotypic spectrum of this rare sarcoma.
  • Histologically, 46 cases (73%) showed only typical features of ES, 9 cases (16%) showed features of PNET, 3 cases (5%) showed "adamantinoma-like" features, 3 cases (5%) corresponded to "atypical Ewing sarcoma," 3 cases (5%) showed principally intersecting fascicles of spindled cells, and 2 cases had abundant hyalinized matrix.
  • HMWCK was expressed only in "adamantinoma-like" EFTs, none of which expressed DES.
  • In conclusion, most, but not all, EFTs can be accurately diagnosed using time-honored morphologic criteria and ancillary immunohistochemistry.
  • However, genetic confirmation remains essential for the diagnosis of unusual morphologic variants of EFT, including "adamantinoma-like," spindled, sclerosing, and clear cell/anaplastic variants.
  • Therefore, to exclude or confirm the diagnosis of Ewing's sarcoma in round cell sarcomas having a variety of patterns but not specifically conforming to a tumor of known lineage (eg, rhabdomyosarcoma), cytogenetics, and/or molecular analysis is required.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16006796.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / CD99 protein, human; 0 / Cell Adhesion Molecules; 0 / Desmin; 0 / FLII protein, human; 0 / Gelsolin; 0 / Microfilament Proteins; 0 / Receptors, Cytoplasmic and Nuclear; 68238-35-7 / Keratins; EC 2.7.10.1 / Proto-Oncogene Proteins c-kit
  •  go-up   go-down


42. Weber K, Damron TA, Frassica FJ, Sim FH: Malignant bone tumors. Instr Course Lect; 2008;57:673-88
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Rare tumors such as chordoma and adamantinoma have anatomic predilections for the sacrum and tibia, respectively.
  • The primary symptom of a patient with a malignant bone tumor is pain, which often occurs at rest or at night.
  • Patients with a likely malignancy require thorough staging to determine the extent of disease and a well-planned biopsy for accurate diagnosis.
  • Knowledge of specific tumor characteristics and treatment options for osteosarcoma, Ewing's sarcoma, chondrosarcoma, malignant fibrous histiocytoma, chordoma, and adamantinoma is important.

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18399615.001).
  • [ISSN] 0065-6895
  • [Journal-full-title] Instructional course lectures
  • [ISO-abbreviation] Instr Course Lect
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Number-of-references] 42
  •  go-up   go-down


43. Requena L, Kutzner H: Seborrheic keratosis with pseudorosettes and adamantinoid seborrheic keratosis: two new histopathologic variants. J Cutan Pathol; 2006 Sep;33 Suppl 2:42-5
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: One lesion showed abundant intercellular mucin, closely resembling to adamantinoma, and therefore was named adamantinoid seborrheic keratosis.
  • [MeSH-major] Adamantinoma / pathology. Keratinocytes / pathology. Keratosis, Seborrheic / pathology. Skin Neoplasms / pathology

  • Genetic Alliance. consumer health - Keratosis, seborrheic.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16972954.001).
  • [ISSN] 0303-6987
  • [Journal-full-title] Journal of cutaneous pathology
  • [ISO-abbreviation] J. Cutan. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


44. Ieni A, Barresi V, Grosso M, Rosa MA, Tuccari G: Lactoferrin immuno-expression in human normal and neoplastic bone tissue. J Bone Miner Metab; 2009;27(3):364-71

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Lactoferrin (Lf) expression was investigated by using a Lf monoclonal antibody in 50 formalin-fixed and paraffin-embedded human bone tumours [10 giant cell tumours (GCTs), 7 osteoid osteomas, 6 ossifying fibromas, 19 enchondromas, 2 chondroblastomas, 2 chondrosarcomas, 2 chondroblastic osteosarcomas, 1 myeloma and 1 adamantinoma] as well as in 8 samples of adult and foetal human normal bone specimens.
  • Lf immuno-expression with a variable ID score was encountered in 19/50 tumours and specifically in 10/10 GCTs, in 5/7 osteoid osteomas, in 2/2 chondroblastomas as well as in the adamantinoma and in the myeloma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Res. 1995 Mar 1;55(5):1168-75 [7867003.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2198-203 [9122171.001]
  • [Cites] Oncol Rep. 2007 May;17(5):1021-6 [17390038.001]
  • [Cites] Bone Miner. 1992 Jan;16(1):37-48 [1531620.001]
  • [Cites] Histol Histopathol. 2002 Oct;17 (4):1077-83 [12371135.001]
  • [Cites] Blood. 1984 Nov;64(5):1103-9 [6593100.001]
  • [Cites] Oncol Rep. 2006 Aug;16(2):257-63 [16820900.001]
  • [Cites] Biometals. 2004 Jun;17(3):331-5 [15222486.001]
  • [Cites] J Pathol. 1999 Dec;189(4):463-9 [10629544.001]
  • [Cites] Eur J Histochem. 2005 Jan-Mar;49(1):33-8 [15823792.001]
  • [Cites] Cancer. 1985 Jun 1;55(11):2612-7 [3888366.001]
  • [Cites] Biochem Cell Biol. 2002;80(1):1-6 [11908632.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1984;403(1):59-66 [6202054.001]
  • [Cites] Haematologica. 1995 May-Jun;80(3):252-67 [7672721.001]
  • [Cites] Biochim Biophys Acta. 1998 Apr 24;1402(3):277-87 [9606986.001]
  • [Cites] Int J Cancer. 2005 Mar 20;114(2):299-306 [15543612.001]
  • [Cites] Mol Hum Reprod. 2002 Jan;8(1):58-67 [11756570.001]
  • [Cites] Virchows Arch A Pathol Anat Histol. 1981;394(1-2):61-73 [6278702.001]
  • [Cites] Clin Cancer Res. 2004 Dec 15;10(24):8683-6 [15623653.001]
  • [Cites] Mol Hum Reprod. 2000 May;6(5):469-73 [10775652.001]
  • [Cites] J Bone Miner Res. 1996 Oct;11(10):1453-60 [8889845.001]
  • [Cites] Comp Biochem Physiol B. 1971 May 15;39(1):119-29 [4998849.001]
  • [Cites] Cell Mol Life Sci. 2005 Nov;62(22):2576-87 [16261253.001]
  • [Cites] J Cell Biochem. 1999 Sep 1;74(3):486-98 [10412049.001]
  • [Cites] J Clin Pathol. 1984 Jan;37(1):51-5 [6323544.001]
  • [Cites] J Clin Pathol. 1978 Apr;31(4):316-27 [346612.001]
  • [Cites] Histol Histopathol. 1992 Oct;7(4):543-7 [1457975.001]
  • [Cites] Exp Cell Res. 1999 Sep 15;251(2):257-63 [10471311.001]
  • [Cites] Eur J Histochem. 1999;43(4):317-22 [10682270.001]
  • [Cites] Arch Pathol Lab Med. 1989 Aug;113(8):912-5 [2757492.001]
  • [Cites] Clin Med Res. 2005 May;3(2):93-101 [16012127.001]
  • [Cites] J Cell Physiol. 1986 Jun;127(3):349-56 [2423539.001]
  • [Cites] Ann Pathol. 1992;12(6):347-52 [1294156.001]
  • [Cites] J Cell Physiol. 1992 Dec;153(3):477-82 [1447310.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1985;406(1):67-74 [3922110.001]
  • [Cites] Pathol Res Pract. 1987 Jun;182(3):344-51 [3628093.001]
  • [Cites] Eur J Biochem. 1989 Dec 8;186(1-2):367-73 [2557211.001]
  • [Cites] Immunol Today. 1995 Sep;16(9):417-9 [7546203.001]
  • [Cites] J Histochem Cytochem. 1983 Feb;31(2):336-44 [6300220.001]
  • [Cites] Hum Pathol. 2003 Oct;34(10):983-93 [14608531.001]
  • [Cites] Physiol Rev. 1984 Jan;64(1):65-102 [6420813.001]
  • [Cites] Science. 1999 Apr 2;284(5411):143-7 [10102814.001]
  • [Cites] Histol Histopathol. 1997 Jul;12(3):671-6 [9225149.001]
  • [Cites] Biochem Cell Biol. 2002;80(1):131-6 [11908637.001]
  • [Cites] Annu Rev Nutr. 1995;15:93-110 [8527233.001]
  • [Cites] Biotechnol Appl Biochem. 2001 Dec;34(Pt 3):151-9 [11730482.001]
  • (PMID = 19240970.001).
  • [ISSN] 0914-8779
  • [Journal-full-title] Journal of bone and mineral metabolism
  • [ISO-abbreviation] J. Bone Miner. Metab.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] EC 3.4.21.- / Lactoferrin
  •  go-up   go-down


45. Almeida Herrero F, Silvestre Muñoz A, Martinez Rodriguez M, Gomar Sancho F: Ossifying fibroma of long bones in adults: a case report. Acta Orthop Belg; 2006 Dec;72(6):786-9
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • No epitheloid cells are found as in adamantinoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17260623.001).
  • [ISSN] 0001-6462
  • [Journal-full-title] Acta orthopaedica Belgica
  • [ISO-abbreviation] Acta Orthop Belg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Belgium
  • [Chemical-registry-number] 0 / Bone Substitutes
  •  go-up   go-down


46. Sakellariou VI, Mavrogenis AF, Papagelopoulos PJ: Limb salvage surgery using the intramedullary diaphyseal segmental defect fixation system. J Long Term Eff Med Implants; 2008;18(1):59-67
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Histological diagnosis included adamantinoma, synovial sarcoma, multiple myeloma, metastatic renal cell carcinoma, myeloid carcinoma of the thyroid gland, and adenocarcinoma of the stomach.
  • At the latest examination, five patients were free of local or distant disease and one patient had deceased with distant disease, without evidence of local recurrence.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19348612.001).
  • [ISSN] 1050-6934
  • [Journal-full-title] Journal of long-term effects of medical implants
  • [ISO-abbreviation] J Long Term Eff Med Implants
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


47. Vera Sempere FJ, Artes Martínez MJ, Vera Sirera B, Bonet Marco J: Follicular adenomatoid odontogenic tumor: immunohistochemical study. Med Oral Patol Oral Cir Bucal; 2006 Jul;11(4):E305-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Follicular adenomatoid odontogenic tumor: immunohistochemical study.
  • Adenomatoid odontogenic tumor (AOT) is an uncommon benign odontogenic lesion that affects young patients, with female predominance, mainly in second decade, showing a radiolucent unilocular image associated with an unerupted tooth, usually a canine.
  • In spite of previous and confusing denominations, such as adenoameloblastoma or adenomatoid ameloblastic tumor, AOT is a benign tumor with a very low rate of recurrence, that show a peculiar morphological picture (basaloid appearance with glandular-like structures, calcifying areas, and amiloid-like material) that allow its histopathological recognition.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16816813.001).
  • [ISSN] 1698-6946
  • [Journal-full-title] Medicina oral, patología oral y cirugía bucal
  • [ISO-abbreviation] Med Oral Patol Oral Cir Bucal
  • [Language] eng; spa
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


48. Ulmar B, Delling G, Werner M, Huch K, Reichel H: Classical and atypical location of adamantinomas--presentation of two cases. Onkologie; 2006 Jun;29(6):276-8
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The diagnostic work-up including biopsy verified an adamantinoma in both cases.
  • In the younger patient, the tumor was located in the metatarsals 4 and 5, in the older patient in the left tibial diaphyses.
  • In both patients, an en-bloc resection of the tumor with wide surgical margins was performed.
  • [MeSH-major] Adamantinoma / diagnosis. Adamantinoma / surgery. Bone Neoplasms / diagnosis. Bone Neoplasms / surgery. Metatarsal Bones / surgery. Tibia / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16783903.001).
  • [ISSN] 0378-584X
  • [Journal-full-title] Onkologie
  • [ISO-abbreviation] Onkologie
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


49. Choi E, Wert M, Guerrieri C, Tucci J: A pathologic fracture of an intracortical chondroma masking as an osteoid osteoma. Orthopedics; 2010 Nov;33(11):845
MedlinePlus Health Information. consumer health - Leg Injuries and Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The differential diagnosis of a tibial intracortical diaphyseal lesion includes osteoid osteoma, periosteal chondroma, nonossifying fibroma, osteofibrous dysplasia, and adamantinoma.

  • Genetic Alliance. consumer health - Chondroma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010, SLACK Incorporated.
  • (PMID = 21053879.001).
  • [ISSN] 1938-2367
  • [Journal-full-title] Orthopedics
  • [ISO-abbreviation] Orthopedics
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


50. Llombart-Bosch A, Machado I, Navarro S, Bertoni F, Bacchini P, Alberghini M, Karzeladze A, Savelov N, Petrov S, Alvarado-Cabrero I, Mihaila D, Terrier P, Lopez-Guerrero JA, Picci P: Histological heterogeneity of Ewing's sarcoma/PNET: an immunohistochemical analysis of 415 genetically confirmed cases with clinical support. Virchows Arch; 2009 Nov;455(5):397-411
Faculty of 1000. commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine. (subscription/membership/fee required).

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ewing's sarcoma (ES)/peripheral neuroectodermal tumor (PNET) are malignant neoplasms affecting children and young adults.
  • This study confirms the structural heterogeneity of ES/PNET, distinguishing three major subtypes: conventional ES (280 cases); PNET (53 cases); and atypical ES/PNET (80), including large cells, vascular-like patterns, spindle pattern, and adamantinoma-like configuration.
  • [MeSH-major] Antibodies. Biomarkers, Tumor / analysis. Bone Neoplasms / pathology. Neuroectodermal Tumors, Primitive, Peripheral / pathology. Sarcoma, Ewing / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Antigens, CD / biosynthesis. Antigens, CD57 / biosynthesis. Antigens, CD99. Caveolin 1 / biosynthesis. Cell Adhesion Molecules / biosynthesis. Child. Child, Preschool. Disease Progression. Female. Humans. Immunohistochemistry. In Situ Hybridization, Fluorescence. Infant. Kaplan-Meier Estimate. Male. Middle Aged. Prognosis. Proto-Oncogene Protein c-fli-1 / biosynthesis. Young Adult

  • Genetic Alliance. consumer health - Ewing's Sarcoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Oncol. 2000 Feb;18(4):885-92 [10673532.001]
  • [Cites] Pathol Res Pract. 1979 Dec;166(1):112-22 [551397.001]
  • [Cites] Klin Padiatr. 2004 Nov-Dec;216(6):315-22 [15565546.001]
  • [Cites] Cancer. 1987 Dec 15;60(12):2958-64 [3499971.001]
  • [Cites] Am J Clin Pathol. 2002 Feb;117(2):225-34 [11863219.001]
  • [Cites] Am J Surg Pathol. 2005 Aug;29(8):1025-33 [16006796.001]
  • [Cites] Cancer Cell. 2003 Dec;4(6):499-515 [14706341.001]
  • [Cites] Diagn Mol Pathol. 2002 Mar;11(1):9-15 [11854596.001]
  • [Cites] Histopathology. 2006 Mar;48(4):363-76 [16487358.001]
  • [Cites] Virchows Arch. 1998 Jul;433(1):35-40 [9692823.001]
  • [Cites] Histopathology. 2006 Dec;49(6):569-75 [17163841.001]
  • [Cites] Mol Diagn Ther. 2008;12(6):359-74 [19035623.001]
  • [Cites] Eur J Cancer. 1995;31A(3):307-14 [7786593.001]
  • [Cites] Appl Immunohistochem Mol Morphol. 2001 Sep;9(3):255-60 [11556754.001]
  • [Cites] Tumori. 1999 Mar-Apr;85(2):101-7 [10363075.001]
  • [Cites] JAMA. 1995 Feb 15;273(7):553-7 [7530783.001]
  • [Cites] J Clin Oncol. 1997 Jul;15(7):2611-21 [9215832.001]
  • [Cites] Semin Immunol. 2008 Dec;20(6):309-10 [18938087.001]
  • [Cites] Hum Pathol. 1996 Apr;27(4):408-16 [8617485.001]
  • [Cites] J Clin Oncol. 2000 May;18(10):2187-8 [10811686.001]
  • [Cites] J Clin Oncol. 2000 Jan;18(1):4-11 [10623687.001]
  • [Cites] Virchows Arch. 1998 Oct;433(4):385-9 [9808442.001]
  • [Cites] Arch Pathol Lab Med. 2006 Aug;130(8):1199-207 [16879024.001]
  • [Cites] Pathol Int. 1998 Jun;48(6):475-80 [9702862.001]
  • [Cites] J Pediatr Hematol Oncol. 2001 May;23 (4):221-4 [11846300.001]
  • [Cites] Am J Surg Pathol. 1994 May;18(5):486-94 [7513503.001]
  • [Cites] Biochem Biophys Res Commun. 1999 Feb 24;255(3):580-6 [10049753.001]
  • [Cites] Anticancer Res. 2007 Jul-Aug;27(4B):2457-63 [17695539.001]
  • [Cites] Gynecol Oncol. 2001 May;81(2):166-71 [11330944.001]
  • [Cites] Am J Surg Pathol. 1993 Jan;17(1):1-13 [8383465.001]
  • [Cites] Mod Pathol. 2006 Jan;19(1):1-8 [16258512.001]
  • [Cites] Am J Physiol Cell Physiol. 2005 Mar;288(3):C494-506 [15692148.001]
  • [Cites] Cancer. 1991 Jan 1;67(1):163-71 [1985713.001]
  • [Cites] Expert Rev Mol Diagn. 2008 Jan;8(1):97-105 [18088234.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1986;409(5):627-40 [3750841.001]
  • [Cites] Cancer. 1992 Feb 15;69(4):1012-20 [1310431.001]
  • [Cites] Indian J Exp Biol. 1997 Apr;35(4):315-22 [9315229.001]
  • [Cites] Am J Clin Pathol. 1996 Nov;106(5):620-4 [8929472.001]
  • [Cites] Am J Surg Pathol. 1995 Oct;19(10 ):1115-23 [7573670.001]
  • [Cites] Am J Clin Pathol. 2006 Mar;125(3):392-8 [16613342.001]
  • [Cites] Semin Diagn Pathol. 1996 Aug;13(3):149-52 [8875706.001]
  • [Cites] Semin Immunol. 2008 Dec;20(6):311-6 [19036608.001]
  • [Cites] Am J Surg Pathol. 1998 Mar;22(3):327-32 [9500774.001]
  • [Cites] Diagn Mol Pathol. 1998 Feb;7(1):29-35 [9646032.001]
  • [Cites] J Clin Pathol. 2005 Oct;58(10):1051-6 [16189150.001]
  • [Cites] Immunogenetics. 1992;35(4):283-5 [1541488.001]
  • [Cites] Pathol Res Pract. 2005;201(8-9):545-9 [16259106.001]
  • [Cites] Am J Surg Pathol. 2000 Mar;24(3):410-6 [10716155.001]
  • [Cites] Cancer Res. 2005 Oct 15;65(20):9226-35 [16230383.001]
  • [Cites] Mod Pathol. 2004 May;17(5):547-52 [15001993.001]
  • [Cites] Cell Cycle. 2009 May 1;8(9):1396-401 [19342880.001]
  • [Cites] Cancer Res. 1991 Jan 1;51(1):336-40 [1988096.001]
  • [Cites] Arch Pathol Lab Med. 2006 Dec;130(12):1813-8 [17149955.001]
  • [Cites] Cancer Res. 2006 Oct 15;66(20):9937-47 [17047056.001]
  • [Cites] Diagn Mol Pathol. 2009 Dec;18(4):189-99 [19861898.001]
  • [Cites] Mod Pathol. 2006 May;19(5):659-68 [16528378.001]
  • [Cites] Science. 2001 Sep 28;293(5539):2449-52 [11498544.001]
  • [Cites] Am J Surg Pathol. 1999 Feb;23 (2):159-65 [9989842.001]
  • [Cites] Cancer Biol Ther. 2004 Oct;3(10):931-41 [15539932.001]
  • [Cites] Histopathology. 1990 May;16(5):461-7 [2163356.001]
  • [Cites] Hum Pathol. 1999 Aug;30(8):911-8 [10452503.001]
  • [Cites] Am J Surg Pathol. 2000 Dec;24(12 ):1657-62 [11117787.001]
  • [Cites] Pediatr Dev Pathol. 2006 Nov-Dec;9(6):488-95 [17163788.001]
  • [Cites] N Engl J Med. 1994 Aug 4;331(5):294-9 [8022439.001]
  • [Cites] Am J Surg Pathol. 1984 Dec;8(12):885-98 [6083729.001]
  • [Cites] Oncol Rep. 2007 Sep;18(3):601-9 [17671707.001]
  • [Cites] Am J Surg Pathol. 2001 Feb;25(2):273-4 [11176079.001]
  • [Cites] Pathol Res Pract. 1993 Feb;189(1):26-32 [8516214.001]
  • [Cites] Acta Oncol. 2000;39(1):111-6 [10752664.001]
  • [Cites] Am J Surg Pathol. 1980 Feb;4(1):29-36 [7361993.001]
  • [Cites] Arch Pathol Lab Med. 2006 Feb;130(2):153-7 [16454553.001]
  • [Cites] Chest. 2004 May;125(5 Suppl):106S [15136443.001]
  • [Cites] Paediatr Drugs. 2001;3(12):899-913 [11772151.001]
  • [Cites] J Clin Oncol. 1998 Apr;16(4):1248-55 [9552022.001]
  • [Cites] Diagn Mol Pathol. 2000 Sep;9(3):137-44 [10976720.001]
  • [Cites] Br J Cancer. 2008 Mar 11;98(5):931-40 [18283322.001]
  • [Cites] Semin Diagn Pathol. 1996 Aug;13(3):250-7 [8875713.001]
  • [Cites] J Clin Oncol. 2006 Jan 1;24(1):152-9 [16382125.001]
  • [Cites] Am J Pathol. 1993 Nov;143(5):1294-300 [8238248.001]
  • [Cites] Sarcoma. 1999;3(1):25-32 [18521261.001]
  • [Cites] Semin Diagn Pathol. 1996 Aug;13(3):153-70 [8875707.001]
  • [Cites] Histopathology. 1993 Dec;23(6):557-61 [8314240.001]
  • [Cites] Cancer. 1978 Apr;41(4):1362-73 [346195.001]
  • [Cites] Cancer. 1979 Jun;43(6):2438-51 [222426.001]
  • [Cites] Cancer Res. 2007 Aug 15;67(16):7675-85 [17699771.001]
  • (PMID = 19841938.001).
  • [ISSN] 1432-2307
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antibodies; 0 / Antigens, CD; 0 / Antigens, CD57; 0 / Antigens, CD99; 0 / Biomarkers, Tumor; 0 / CAV1 protein, human; 0 / CD99 protein, human; 0 / Caveolin 1; 0 / Cell Adhesion Molecules; 0 / FLI1 protein, human; 0 / Proto-Oncogene Protein c-fli-1
  •  go-up   go-down


51. Ramseier LE, Malinin TI, Temple HT, Mnaymneh WA, Exner GU: Allograft reconstruction for bone sarcoma of the tibia in the growing child. J Bone Joint Surg Br; 2006 Jan;88(1):95-9
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Two had Ewing's sarcoma, one an adamantinoma and 16 osteosarcoma, one with multifocal disease.
  • Five patients have died; the other 14 were free from disease at the time of follow-up.
  • [MeSH-minor] Adamantinoma / surgery. Adolescent. Child. Female. Follow-Up Studies. Humans. Leg Length Inequality / etiology. Male. Reoperation / methods. Sarcoma, Ewing / surgery. Treatment Outcome. Wound Healing

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Bone Grafts.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16365128.001).
  • [ISSN] 0301-620X
  • [Journal-full-title] The Journal of bone and joint surgery. British volume
  • [ISO-abbreviation] J Bone Joint Surg Br
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] England
  •  go-up   go-down


52. Papagelopoulos PJ, Savvidou OD, Mavrogenis AF, Galanis EC, Shaughnessy WJ, Unni KK, Sim FH: Lateral malleolus en bloc resection and ankle reconstruction for malignant tumors. Clin Orthop Relat Res; 2005 Aug;(437):209-18
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There were four osteosarcomas, three chondrosarcomas, two Ewing's sarcomas, and one adamantinoma.
  • At the latest followup, all 10 patients showed no evidence of disease.
  • Five patients who had primary or late ankle arthrodesis had a Musculoskeletal Tumor Society and International Society of Limb Salvage functional score of 28 points (92%), and two adolescents who had postoperative bracing alone had a functional score of 24 points (80%).

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16056051.001).
  • [ISSN] 0009-921X
  • [Journal-full-title] Clinical orthopaedics and related research
  • [ISO-abbreviation] Clin. Orthop. Relat. Res.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


53. Weinreb I, Goldstein D, Perez-Ordoñez B: Primary extraskeletal Ewing family tumor with complex epithelial differentiation: a unique case arising in the lateral neck presenting with Horner syndrome. Am J Surg Pathol; 2008 Nov;32(11):1742-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary extraskeletal Ewing family tumor with complex epithelial differentiation: a unique case arising in the lateral neck presenting with Horner syndrome.
  • Focally, the tumor abruptly produced keratinizing cells and frank squamous pearls.
  • The tumor showed diffuse expression of CD99, high molecular weight keratin, p63, cytokeratin (CK) 5/6, AE1/AE3, CAM5.2, CK19, and focal CK14.
  • Subsequently, the tumor was shown to harbor the t(11;22) involving EWSR1 and FLI-1 by reverse transcription-polymerase chain reaction, characteristic of EFT's, which was confirmed by dual color break apart fluorescence in-situ hybridization analysis.
  • This tumor is related to, if not an example of the recently described "adamantinoma-like" EFT and demonstrates a potential diagnostic pitfall.
  • [MeSH-minor] Adult. Biomarkers, Tumor / analysis. Humans. Immunohistochemistry. In Situ Hybridization, Fluorescence. Keratins / biosynthesis. Male. Membrane Proteins / biosynthesis. Oncogene Proteins, Fusion / genetics. Proto-Oncogene Protein c-fli-1 / genetics. RNA-Binding Protein EWS. Reverse Transcriptase Polymerase Chain Reaction. Translocation, Genetic. Vagus Nerve / pathology

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18769338.001).
  • [ISSN] 1532-0979
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / CKAP4 protein, human; 0 / EWS-FLI fusion protein; 0 / Membrane Proteins; 0 / Oncogene Proteins, Fusion; 0 / Proto-Oncogene Protein c-fli-1; 0 / RNA-Binding Protein EWS; 68238-35-7 / Keratins
  •  go-up   go-down


54. Jeon DG, Lee SY, Kim JW: Bone primary sarcomas undergone unplanned intralesional procedures - the possibility of limb salvage and their oncologic results. J Surg Oncol; 2006 Dec 1;94(7):592-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • An unplanned surgical excision occurs when tumors are removed without the appropriate preoperative evaluation and consideration for the need to obtain tumor-free margins.
  • Residual tumor tissue as a result of unplanned excision of soft tissue sarcoma is a risk factor for local recurrence.
  • There were 22 (88%) cases of osteosarcomas, 2 (8%) MFH of bone and 1 (4%) adamantinoma.

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2006 Wiley-Liss, Inc.
  • (PMID = 17066433.001).
  • [ISSN] 0022-4790
  • [Journal-full-title] Journal of surgical oncology
  • [ISO-abbreviation] J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


55. Wysluch A, Hölzle F, Maurer P: [Giant ameloblastoma of the jaw]. HNO; 2009 Nov;57(11):1193-6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Giant ameloblastoma of the jaw].
  • [Transliterated title] Monströses Ameloblastom des Unterkiefers.
  • Ameloblastomas represent benign, epithelial alveolar tumors, which originate from epithelial enamel cells (ameloblasts).
  • As demonstrated by the case of a 71-year-old patient with giant ameloblastoma of the upper jaw, early resection is recommended.
  • [MeSH-major] Ameloblastoma / diagnosis. Mandibular Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Dec;104(6):e17-24 [17942338.001]
  • [Cites] J Craniomaxillofac Surg. 1993 Dec;21(8):351-5 [8113429.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Oct;104(4):478-85 [17524681.001]
  • [Cites] Mund Kiefer Gesichtschir. 2006 Jan;10(1):1-2 [16328532.001]
  • [Cites] Radiographics. 1999 Sep-Oct;19(5):1107-24 [10489168.001]
  • [Cites] Am J Otolaryngol. 2002 Jan-Feb;23 (1):44-8 [11791248.001]
  • [Cites] Plast Reconstr Surg. 1972 Sep;50(3):242-8 [4115148.001]
  • [Cites] Niger Postgrad Med J. 2008 Mar;15(1):1-5 [18408774.001]
  • [Cites] Int J Oral Maxillofac Surg. 2007 Apr;36(4):283-8 [17222535.001]
  • (PMID = 19727626.001).
  • [ISSN] 1433-0458
  • [Journal-full-title] HNO
  • [ISO-abbreviation] HNO
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


56. Wang J, Zhang RY: [Ectopic hamartomatous thymoma: a clinicopathological and immunohistochemical study of two cases]. Zhonghua Bing Li Xue Za Zhi; 2005 Jul;34(7):397-401
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • They formed small solid islands and adamantinoma-like "nastomosing cords", or appeared as lining cells in large cystic spaces.
  • CONCLUSIONS: EHT is a benign tumor that occurs predominantly in the lower neck region of young to middle-aged males.
  • Immunohistochemical study revealed myoepithelial differentiation of the spindle cells, suggesting EHT is a mixed tumor composed of epithelial and myoepithelial cells.
  • EHT possibly originates from the remnants of cervical sinus of His, and therefore, may be renamed as branchial anlage mixed tumor.

  • MedlinePlus Health Information. consumer health - Lymphatic Diseases.
  • MedlinePlus Health Information. consumer health - Thymus Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16251042.001).
  • [ISSN] 0529-5807
  • [Journal-full-title] Zhonghua bing li xue za zhi = Chinese journal of pathology
  • [ISO-abbreviation] Zhonghua Bing Li Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Anion Exchange Protein 1, Erythrocyte; 0 / Keratins, Type II; 0 / Mucin-1; 0 / Vimentin
  •  go-up   go-down


57. Abada RL, Kadiri F, Tawfik N, Benchakroun N, Bouchbika Z, Chekkoury AI, Benchakroun Y, Benider A: [Multiple metastases of a mandibular ameloblastoma]. Rev Stomatol Chir Maxillofac; 2005 Jun;106(3):177-80

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Multiple metastases of a mandibular ameloblastoma].
  • INTRODUCTION: Ameloblastoma is a benign odontogenic tumor which can be locally aggressive and invasive.
  • Metastases are rare but possible and must be considered as a malignant form of the tumor.
  • OBSERVATION: A 50-year-old woman presented a jugal metastasis of a mandibular ameloblastom which had been treated several times 28 years earlier.
  • DISCUSSION: The absence of any histological sign of malignity in the primary tumor and in the metastases, as observed in our patient, is remarkable.
  • Progression is very slow, like for the primary tumor.
  • Several factors predictive of metastasis have been described: female gender, age at onset of primary tumor (2nd to 3rd decade) and multiple local recurrences.
  • [MeSH-major] Ameloblastoma / secondary. Mandibular Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15976707.001).
  • [ISSN] 0035-1768
  • [Journal-full-title] Revue de stomatologie et de chirurgie maxillo-faciale
  • [ISO-abbreviation] Rev Stomatol Chir Maxillofac
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


58. Vallicioni J, Loum B, Dassonville O, Poissonnet G, Ettore F, Demard F: [Ameloblastomas]. Ann Otolaryngol Chir Cervicofac; 2007 Sep;124(4):166-71

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Ameloblastomas].
  • OBJECTIVES: The aim of this work was to report on the clinical, radiological and histological characteristics of ameloblastomas concerning bone structures of the face, rare but not exceptional tumours, and to communicate our experience of their treatment.
  • MATERIAL AND METHODS: The authors reexamined six recent cases of patients presenting with ameloblastoma at the centre Antoine Lacassagne in Nice.
  • The diagnostic context, the treatment and the development of the disease are given in detail, emphasizing the frequency of local relapse of this histologically benign condition.
  • RESULTS: The study of these cases confirmed the benefit of surgical treatment of ameloblastoma.
  • [MeSH-major] Ameloblastoma / epidemiology. Ameloblastoma / pathology. Mandibular Neoplasms / epidemiology. Mandibular Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17673157.001).
  • [ISSN] 0003-438X
  • [Journal-full-title] Annales d'oto-laryngologie et de chirurgie cervico faciale : bulletin de la Société d'oto-laryngologie des hôpitaux de Paris
  • [ISO-abbreviation] Ann Otolaryngol Chir Cervicofac
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


59. Mendenhall WM, Werning JW, Fernandes R, Malyapa RS, Mendenhall NP: Ameloblastoma. Am J Clin Oncol; 2007 Dec;30(6):645-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ameloblastoma.
  • The purpose of this article is to review the pertinent literature and discuss the optimal treatment and outcomes for patients with ameloblastoma.
  • Ameloblastoma is an uncommon benign, locally aggressive odontogenic neoplasm that usually occurs in the vicinity of the mandibular molars or ramus.
  • Uncontrolled, ameloblastoma may cause significant morbidity and occasionally death.
  • The majority of ameloblastomas are multicystic, which are more difficult to eradicate than the unicystic and peripheral varieties.
  • In contrast, conservative procedures such as enucleation and/or curettage result in local control rates of approximately 80% and 50% for unicystic and multicystic ameloblastomas, respectively.
  • Limited experience with radiotherapy indicates that it may reduce the risk of progression and result in long-term local control in the occasional patient with incompletely resectable disease.
  • The optimal treatment for ameloblastoma is wide en bloc resection.
  • Radiotherapy may improve the likelihood of local control in the occasional patient with incompletely resectable tumor.
  • [MeSH-major] Ameloblastoma / radiotherapy. Ameloblastoma / surgery. Jaw Neoplasms / radiotherapy. Jaw Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18091060.001).
  • [ISSN] 1537-453X
  • [Journal-full-title] American journal of clinical oncology
  • [ISO-abbreviation] Am. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 27
  •  go-up   go-down


60. Gilijamse M, Leemans CR, Winters HA, Schulten EA, van der Waal I: Metastasizing ameloblastoma. Int J Oral Maxillofac Surg; 2007 May;36(5):462-4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastasizing ameloblastoma.
  • Ameloblastomas are locally invasive tumours of odontogenic origin with a high propensity for local recurrence.
  • Here is presented a case of a 26-year-old woman with a recurrent ameloblastoma of the mandible and a metastatic lymph node in the homolateral neck.
  • [MeSH-major] Ameloblastoma / secondary. Lymphatic Metastasis / pathology. Mandibular Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17275258.001).
  • [ISSN] 0901-5027
  • [Journal-full-title] International journal of oral and maxillofacial surgery
  • [ISO-abbreviation] Int J Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


61. Black CC, Addante RR, Mohila CA: Intraosseous ameloblastoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Nov;110(5):585-92

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intraosseous ameloblastoma.
  • Ameloblastomas are benign slow-growing aggressive neoplasms with a poorly understood potential for rare metastasis.
  • Microscopically, ameloblastomas are recognizable from their recapitulation of embryologic ameloblasts and stellate reticulum.
  • Treatment planning for a given tumor includes consideration of location, primary versus recurrent, size, presence of cortical perforation, and age and health of the patient.
  • [MeSH-major] Ameloblastoma / diagnosis. Jaw Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Mosby, Inc. All rights reserved.
  • [CommentIn] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 May;111(5):536; author reply 536-8 [21306924.001]
  • (PMID = 20580278.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


62. Essaadi M, Sif A, Benzaouia A, Rouadi S, Abada RL, Mahtar M, Roubal M, Janah A, Kadiri F, Rifki A: [Recurrent ameloblastoma on a rib graft after 33 years (a case report and review of the literature)]. Rev Laryngol Otol Rhinol (Bord); 2010;131(4-5):303-6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Recurrent ameloblastoma on a rib graft after 33 years (a case report and review of the literature)].
  • INTRODUCTION: The recurrence of an ameloblastoma is generally due to insufficient margins of resection or to the aggressiveness of the tumour which is regarded as locally malignant.
  • We report the case of a recurrent ameloblastoma on autologus rib graft which occurred 33 years after the surgery.
  • The histopathologic diagnosis was an ameloblastoma with healthy limits and without invasion of the soft tissues.
  • CONCLUSION: The pathogenesis of the recurrence of an ameloblastoma on autologus osseous graft is still not well understood.
  • [MeSH-major] Ameloblastoma / pathology. Mandibular Neoplasms / pathology. Neoplasm Recurrence, Local / pathology. Ribs / transplantation

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21866745.001).
  • [ISSN] 0035-1334
  • [Journal-full-title] Revue de laryngologie - otologie - rhinologie
  • [ISO-abbreviation] Rev Laryngol Otol Rhinol (Bord)
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] France
  •  go-up   go-down


63. Atalay B, Soluk M, Brkić A, Emes Y, Cetin O, Olgac V: Desmoplastic ameloblastoma. J Craniofac Surg; 2009 Nov;20(6):2256-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Desmoplastic ameloblastoma.
  • Ameloblastoma is a rare benign odontogenic epithelial tumor characterized by abnormal cell growth, which easily infiltrates and destroys surrounding bony tissues.
  • One of the 3 clinical variants of ameloblastoma is desmoplastic type, with involvement of the maxillary arch more often than the mandible.
  • Its histopathologic variant characterized by extensive squamous metaplasia, islands of tumor cells, and sometimes keratin formation is known as desmoplastic acanthomatous ameloblastoma.The aim of this report was to present an unusual case of symphysis located desmoplastic acanthomatous ameloblastoma in a 56-year-old female patient, who was experiencing laryngeal carcinoma 2 years ago.
  • [MeSH-major] Ameloblastoma / pathology. Mandibular Neoplasms / pathology. Neoplasms, Second Primary / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19934686.001).
  • [ISSN] 1536-3732
  • [Journal-full-title] The Journal of craniofacial surgery
  • [ISO-abbreviation] J Craniofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


64. Bansal M, Chaturvedi TP, Bansal R, Kumar M: Acanthomatous ameloblastoma of anterior maxilla. J Indian Soc Pedod Prev Dent; 2010 Jul-Sep;28(3):209-11

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Acanthomatous ameloblastoma of anterior maxilla.
  • The unusual case of acanthomatous ameloblastoma occurring in maxillary left anterior region in a 13-year-old female child is presented with chief complaint of swelling in the upper left anterior region since one year and spacing between maxillary left central incisor and canine.
  • Microscopic examination of surgically excised specimen revealed solid epithelial cell nests with peripheral palisading ameloblastic cells and the central squamous cell assemblage that was consistent with the findings of acanthomatous ameloblastoma type.
  • Acanthomatous ameloblastoma is the extremely rare variant.
  • [MeSH-major] Ameloblastoma / pathology. Maxillary Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21157056.001).
  • [ISSN] 0970-4388
  • [Journal-full-title] Journal of the Indian Society of Pedodontics and Preventive Dentistry
  • [ISO-abbreviation] J Indian Soc Pedod Prev Dent
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


65. Bozza F, Marcelli VA, Pistilli R, Govoni FA, Marsico C: Maxillary ameloblastoma. Minerva Stomatol; 2006 Apr;55(4):215-22

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Maxillary ameloblastoma.
  • Maxillary ameloblastoma is a rare odontogenic neoplasm that is histologically benign and originates from epithelial cells present in bone tissue.
  • The risk, in particularly extensive forms, that the ameloblastoma will invade extra-maxillary structures such as the orbit, the pterygomaxillary fossa, the infratemporal fossa and the base of the skull, means that surgical treatment is difficult if it is to be oncologically radical while respecting function and aesthetics.
  • Our experience in treating 2 cases of maxillary ameloblastoma is reported.
  • [MeSH-major] Ameloblastoma / surgery. Maxillary Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16618996.001).
  • [ISSN] 0026-4970
  • [Journal-full-title] Minerva stomatologica
  • [ISO-abbreviation] Minerva Stomatol
  • [Language] eng; ita
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


66. Etit D, Uyaroglu MA, Erdogan N: Mixed odontogenic tumor: ameloblastoma and calcifying epithelial odontogenic tumor. Indian J Pathol Microbiol; 2010 Jan-Mar;53(1):122-4
Genetic Alliance. consumer health - Calcifying Epithelial Odontogenic Tumor.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mixed odontogenic tumor: ameloblastoma and calcifying epithelial odontogenic tumor.
  • Odontogenic tumors constitute a group of heterogeneous disease derived from epithelial, mesenchymal and/or ectomesenchymal elements.
  • Ameloblastoma is the best known and the most frequent form of odontogenic tumors.
  • Calcifying epithelial odontogenic tumor (CEOT), known as Pindborg tumor, is locally invasive lesion which has a characteristic amiloid deposition.
  • Here a case of a peripheral ameloblastoma associated with CEOT is presented with clinical and morphological features.
  • [MeSH-major] Ameloblastoma / diagnosis. Ameloblastoma / pathology. Odontogenic Tumors / diagnosis. Odontogenic Tumors / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20090240.001).
  • [ISSN] 0974-5130
  • [Journal-full-title] Indian journal of pathology & microbiology
  • [ISO-abbreviation] Indian J Pathol Microbiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


67. Thillaikarasi R, Balaji J, Gupta B, Ilayarja V, Vani NV, Vidula B, Saravanan B, Ponniah I: Cystic granular cell ameloblastoma. J Maxillofac Oral Surg; 2010 Sep;9(3):310-3

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cystic granular cell ameloblastoma.
  • Ameloblastoma is a locally aggressive benign epithelial odontogenic tumor, while unicystic ameloblastoma is a relatively less aggressive variant.
  • Although rare in unicystic or cystic ameloblastoma, granular cell change in ameloblastoma is a recognized phenomenon.
  • The purpose of the present article is to report a case of cystic granular cell ameloblastoma in 34-year old female.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22190813.001).
  • [ISSN] 0974-942X
  • [Journal-full-title] Journal of maxillofacial and oral surgery
  • [ISO-abbreviation] J Maxillofac Oral Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3177435
  • [Keywords] NOTNLM ; Ameloblastoma / Cystic / Granular cell / Odontogenic
  •  go-up   go-down


68. Brooks JK, Al-Mubarak H, Ribera MJ, Cohen PD, Ross DS, Scheper MA: Diminutive, interradicular "hybrid" desmoplastic/acanthomatous ameloblastoma. Quintessence Int; 2010 Mar;41(3):209-12

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diminutive, interradicular "hybrid" desmoplastic/acanthomatous ameloblastoma.
  • Ameloblastomas are benign aggressive odontogentic tumors that exhibit insidious growth rates with attainment of extensive dimesions.
  • Because ameloblastomas are not usually symptomatic until late in their clinical course, few are detected early.
  • This article reports an atypical case of a small, painful ameloblastoma arising between the roots of the mandibular left canine and lateral incisor in a 66-year-old female.
  • Histopathology revealed a "hybrid" ameloblastoma with a pronounced desmoplastic pattern and acanthomatous changes.
  • Timely recognition and intervention of ameloblastomas may improve treatment outcomes.
  • [MeSH-major] Ameloblastoma / pathology. Mandibular Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20213021.001).
  • [ISSN] 1936-7163
  • [Journal-full-title] Quintessence international (Berlin, Germany : 1985)
  • [ISO-abbreviation] Quintessence Int
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


69. Fregnani ER, da Cruz Perez DE, Soares FA, Alves FA: Synchronous ameloblastoma and orthokeratinized odontogenic cyst of the mandible. J Oral Pathol Med; 2006 Oct;35(9):573-5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Synchronous ameloblastoma and orthokeratinized odontogenic cyst of the mandible.
  • The simultaneous occurrence of ameloblastomas with odontogenic cysts or other non-odontogenic lesions have already been described as combined lesions.
  • However, we are unaware of any report in the English literature of simultaneous occurrence of ameloblastoma and orthokeratinized odontogenic cyst (OOC) occurring as completely distinct lesions.
  • This report shows a case of synchronous ameloblastoma and OOC, located on posterior regions of the mandible, but in distinct sides.
  • [MeSH-major] Ameloblastoma / diagnosis. Mandibular Neoplasms / diagnosis. Neoplasms, Multiple Primary / diagnosis. Odontogenic Cysts / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16968239.001).
  • [ISSN] 0904-2512
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


70. Yavagal C, Anegundi RT, Shetty S: Unicystic plexiform ameloblastoma: an insight for pediatric dentists. J Indian Soc Pedod Prev Dent; 2009 Jan-Mar;27(1):70-4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unicystic plexiform ameloblastoma: an insight for pediatric dentists.
  • Ameloblastomas have been categorized broadly into three biologic variants: cystic (unicystic), solid, and peripheral.
  • The term plexiform unicystic ameloblastoma refers to a pattern of epithelial proliferation that has been described in cystic lesions of the jaws.
  • Although the histology suggests that cystic ameloblastomas follow a biologically low-grade course, recent evidence suggests that they may often behave clinically as biologically aggressive tumors.
  • A literature review on the topic has been added along with a case report highlighting the state-of-the-art approach and management of such ameloblastomas, in pediatric patients.
  • [MeSH-major] Ameloblastoma / pathology. Mandibular Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19414980.001).
  • [ISSN] 0970-4388
  • [Journal-full-title] Journal of the Indian Society of Pedodontics and Preventive Dentistry
  • [ISO-abbreviation] J Indian Soc Pedod Prev Dent
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] India
  • [Number-of-references] 14
  •  go-up   go-down


71. Zhang J, Gu Z, Jiang L, Zhao J, Tian M, Zhou J, Duan Y: Ameloblastoma in children and adolescents. Br J Oral Maxillofac Surg; 2010 Oct;48(7):549-54

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ameloblastoma in children and adolescents.
  • This study first reviewed the data of 37 patients aged 18 years and younger with ameloblastoma over a 16-year period and then reviewed the literature on this subject from 1970 to 2009.
  • Of 37 patients with ameloblastoma, 23 were male and 14 were female, a ratio of 1.6:1.
  • A series of literature review disclosed 233 well-documented cases of ameloblastoma in children and adolescents.
  • Owing to a high recurrent rate of ameloblastoma, solid type of tumors should be approached with radical surgical treatment, while conservative measure can be applied selectively to unicystic type.
  • Long-term follow-up is important because recurrence may appear years after tumor removal.
  • [MeSH-major] Ameloblastoma / pathology. Mandibular Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2009 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
  • (PMID = 19783332.001).
  • [ISSN] 1532-1940
  • [Journal-full-title] The British journal of oral & maxillofacial surgery
  • [ISO-abbreviation] Br J Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Scotland
  •  go-up   go-down


72. Odukoya O, Effiom OA: Clinicopathological study of 100 Nigerian cases of ameloblastoma. Niger Postgrad Med J; 2008 Mar;15(1):1-5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinicopathological study of 100 Nigerian cases of ameloblastoma.
  • SUMMARY: Clinicopathological analysis and growth rate study of 100 cases of ameloblastoma was undertaken.
  • The estimated monthly growth rate (EMGR) of ameloblastoma was observed to be slower in males although the mean tumour volume recorded in females was lower than males in the series.
  • The biologic aggression of 4 various types of ameloblastoma was predicted using EMGR and average volume of tumour at hospital presentation as predictive markers.
  • Solid multicystic ameloblastoma was observed with the fastest EMGR of 0.81 cm(3)/month.
  • Peripheral ameloblastoma was observed with the slowest EMGR of 0.17 cm(3)/ month.
  • It was concluded that all the 4 types of ameloblastoma observed were clinically distinct and showed varying biologic aggression.
  • It is therefore necessary to distinguish between the various clinical types of ameloblastoma before a clinician proceeds with definitive treatment.
  • [MeSH-major] Ameloblastoma / pathology. Jaw Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18408774.001).
  • [ISSN] 1117-1936
  • [Journal-full-title] The Nigerian postgraduate medical journal
  • [ISO-abbreviation] Niger Postgrad Med J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Nigeria
  •  go-up   go-down


73. Hasim FW, Poon CC, Smith AC: Prolonged survival with confirmed metastatic pulmonary ameloblastoma. Int J Oral Maxillofac Surg; 2007 Oct;36(10):953-5
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prolonged survival with confirmed metastatic pulmonary ameloblastoma.
  • This report presents a living 94-year-old female with known metastatic pulmonary ameloblastoma diagnosed over 37 years ago.
  • To our knowledge this case represents the longest survival time recorded after appearance of untreated metastatic disease.
  • [MeSH-major] Ameloblastoma / secondary. Lung Neoplasms / secondary. Mandibular Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17408923.001).
  • [ISSN] 0901-5027
  • [Journal-full-title] International journal of oral and maxillofacial surgery
  • [ISO-abbreviation] Int J Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


74. López-Jornet P, Bermejo-Fenoll A: Peripheral ameloblastoma of the gingiva: the importance of diagnosis. J Clin Periodontol; 2005 Jan;32(1):12-5
MedlinePlus Health Information. consumer health - Gum Disease.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Peripheral ameloblastoma of the gingiva: the importance of diagnosis.
  • BACKGROUND: Peripheral ameloblastoma is an extremely rare epithelial odontogenic tumor, limited to the soft tissues of the gums or oral mucosa.
  • METHODS: The present study describes the case of a 31-year-old male presenting a firm, symptomless tumor mass of irregular appearance and measuring approximately 12 mm in diameter, located in the distal zone of 4.7.
  • The diagnosis was peripheral ameloblastoma.
  • Consequently, peripheral ameloblastoma should not be viewed as a harmless mass.
  • [MeSH-major] Ameloblastoma / pathology. Gingival Diseases / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright Blackwell Munksgaard, 2004.
  • (PMID = 15642052.001).
  • [ISSN] 0303-6979
  • [Journal-full-title] Journal of clinical periodontology
  • [ISO-abbreviation] J. Clin. Periodontol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


75. Kawabata T, Takahashi K, Sugai M, Murashima-Suginami A, Ando S, Shimizu A, Kosugi S, Sato T, Nishida M, Murakami K, Iizuka T: Polymorphisms in PTCH1 affect the risk of ameloblastoma. J Dent Res; 2005 Sep;84(9):812-6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Polymorphisms in PTCH1 affect the risk of ameloblastoma.
  • Ameloblastoma is the most common odontogenic tumor, but the genetic nature of the changes in the tumor cells has been unclear.
  • Both CTNNB1 and PTCH1 are important in tooth development and are expressed in ameloblastoma.
  • The aim of this study was to investigate whether genetic alterations of CTNNB1 and PTCH1 are present in ameloblastoma.
  • We investigated 14 cases of ameloblastoma.
  • The polymorphisms found in the ameloblastoma patients were further examined in a subsequent case-control study.
  • We found a CTNNB1 mutation in one case of plexiform-type ameloblastoma.
  • The proportion of CGG8 alleles was significantly higher in the ameloblastoma group.
  • The results of this study indicate a possible relationship between the CGG8 allele in PTCH1 and the risk for ameloblastoma.
  • [MeSH-major] Ameloblastoma / genetics. Receptors, Cell Surface / genetics

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16109989.001).
  • [ISSN] 0022-0345
  • [Journal-full-title] Journal of dental research
  • [ISO-abbreviation] J. Dent. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CTNNB1 protein, human; 0 / Cytoskeletal Proteins; 0 / PTCH protein, human; 0 / Patched Receptors; 0 / Patched-1 Receptor; 0 / Receptors, Cell Surface; 0 / Trans-Activators; 0 / beta Catenin
  •  go-up   go-down


76. Matijević M, Leović D, Popić B, Zubcić V, Kopić V, Prlić A, Siber S, Dinjar K: The importance of thorough preoperative diagnostics of maxillary ameloblastoma: report of three cases. Coll Antropol; 2010 Dec;34(4):1445-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The importance of thorough preoperative diagnostics of maxillary ameloblastoma: report of three cases.
  • Ameloblastoma, especially maxillary, is a rare benign neoplasm of odontogenic origin.
  • Diagnosis of significant number of lesions is usually established postoperatively, because ameloblastoma, especially the unicystic form, mimics wide range of more frequent jaw lesions.
  • From January 1993 to December 2005, three cases of the maxillary ameloblastoma were surgically treated at our Department.
  • The authors present clinical, radiological and pathohistological features of the ameloblastomas in this rare localization with special attention to need of accurate preoperative diagnostics.
  • [MeSH-major] Ameloblastoma / diagnosis. Maxillary Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21874736.001).
  • [ISSN] 0350-6134
  • [Journal-full-title] Collegium antropologicum
  • [ISO-abbreviation] Coll Antropol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Croatia
  •  go-up   go-down


77. Kitkumthorn N, Mutirangura A: LINE-1 methylation difference between ameloblastoma and keratocystic odontogenic tumor. Oral Dis; 2010 Apr;16(3):286-91

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] LINE-1 methylation difference between ameloblastoma and keratocystic odontogenic tumor.
  • Keratocystic odontogenic tumor (KCOT) and ameloblastoma are different tumors but posses the same tissue in origin.
  • Here, we investigated long interspersed nuclear element-1 (LINE-1 or L1) methylation status between ameloblastoma and KCOT.
  • MATERIALS AND METHODS: We studied the methylation levels of the long interspersed nucleotide element-1 (LINE-1) in ameloblastoma and KCOT.
  • After collecting ameloblastoma cells and epithelium lining cells of KCOT by laser capture microdissection from paraffin embedded tissue, combined bisulfite restriction analysis of LINE-1 (COBRALINE-1) was performed to measure LINE-1 methylation levels.
  • RESULTS: The LINE-1 methylation level in KCOT (53.16 +/- 12.03%) was higher than that in ameloblastoma (36.90 +/- 16.52%), with a statistical significance of P = 0.001.
  • CONCLUSION: We found LINE-1 hypomethylation levels between ameloblastoma and KCOT are different.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Ameloblastoma / chemistry. Ameloblastoma / genetics. Child. DNA Methylation. Female. Humans. Keratins. Male. Middle Aged. Promoter Regions, Genetic. Restriction Mapping / methods. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20374511.001).
  • [ISSN] 1601-0825
  • [Journal-full-title] Oral diseases
  • [ISO-abbreviation] Oral Dis
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / DNA, Neoplasm; 68238-35-7 / Keratins
  •  go-up   go-down


78. Muvova L, Dilu N, Sokolo M: [The treatment of choice for recurrent ameloblastoma]. Odontostomatol Trop; 2005 Jun;28(110):13-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [The treatment of choice for recurrent ameloblastoma].
  • 92 patients with recurring ameloblastoma of jawbones were followed.
  • What implies that the preserving surgery on the recurring ameloblastoma is more beneficial than negative with the two races with more than 80%.
  • The authors thus concluded that this surgical method still keeps its place of choice in the treatment of the repetitions of the ameloblastoma and that this factor has a prognostic value.
  • [MeSH-major] Ameloblastoma / surgery. Jaw Neoplasms / surgery. Neoplasm Recurrence, Local / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16245761.001).
  • [ISSN] 0251-172X
  • [Journal-full-title] Odonto-stomatologie tropicale = Tropical dental journal
  • [ISO-abbreviation] Odontostomatol Trop
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Senegal
  •  go-up   go-down


79. Siriwardena BS, Kudo Y, Ogawa I, Tilakaratne WM, Takata T: Aberrant beta-catenin expression and adenomatous polyposis coli gene mutation in ameloblastoma and odontogenic carcinoma. Oral Oncol; 2009 Feb;45(2):103-8
Genetic Alliance. consumer health - Familial Adenomatous Polyposis (FAP).

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Aberrant beta-catenin expression and adenomatous polyposis coli gene mutation in ameloblastoma and odontogenic carcinoma.
  • This study was conducted to clarify the relation of beta-catenin accumulation and the mutation of the CTNNB1 (beta-catenin) gene with the mutation of APC gene in the process of development of odontogenic tumors including ameloblastoma and odontogenic carcinoma (OC).
  • beta-Catenin accumulation was examined by immunohistochemistry in formalin-fixed, paraffin-embedded samples of six ameloblastomas and eight OCs.
  • All ameloblastoma cases and six out of eight (75%) OC cases exhibited beta-catenin accumulation in the nucleus.
  • CTNNB1 mutation was only found in one OC case, whereas three of six (50%) ameloblastoma cases and two out of eight (25%) OC cases had APC mutations within the mutational cluster region.
  • [MeSH-minor] Adult. Ameloblastoma / genetics. Ameloblastoma / metabolism. Ameloblastoma / pathology. Cytoplasm / metabolism. DNA Mutational Analysis. DNA, Neoplasm / analysis. Female. Genes, APC. Humans. Immunohistochemistry. Male. Middle Aged. Molecular Sequence Data

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18486530.001).
  • [ISSN] 1879-0593
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Adenomatous Polyposis Coli Protein; 0 / CTNNB1 protein, human; 0 / DNA, Neoplasm; 0 / beta Catenin
  •  go-up   go-down


80. Correnti M, Rossi M, Avila M, Perrone M, Rivera H: Human papillomavirus in ameloblastoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Sep;110(3):e20-4
MedlinePlus Health Information. consumer health - HPV.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Human papillomavirus in ameloblastoma.
  • OBJECTIVE: Ameloblastomas are benign epithelial tumors of odontogenic origin, with a high recurrence rate and local aggressiveness.
  • A few preliminary studies have demonstrated HPV presence mainly in peripheral ameloblastomas.
  • The purpose of this study was to detect HPV-DNA in intraosseous ameloblastomas.
  • METHODS: Eighteen cases of intraosseous ameloblastomas of different histological variants were selected.
  • Four of the unicystic ameloblastomas were HPV positive; of these, all presented koilocytic changes and were associated with dentigerous cysts, whereas only 2 positive cases corresponded to solid ameloblastomas.
  • CONCLUSIONS: We may conclude that HPV low and high risk was detected in our sample of intraosseous ameloblastomas.
  • [MeSH-major] Alphapapillomavirus / isolation & purification. Ameloblastoma / virology. Mandibular Neoplasms / virology. Papillomavirus Infections / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2010 Mosby, Inc. All rights reserved.
  • (PMID = 20727492.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Viral
  •  go-up   go-down


81. Ereño C, Etxegarai L, Corral M, Basurko JM, Bilbao FJ, López JI: Primary sinonasal ameloblastoma. APMIS; 2005 Feb;113(2):148-50
MedlinePlus Health Information. consumer health - Nasal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary sinonasal ameloblastoma.
  • A case of primary ameloblastoma of the right sinonasal tract in a 66-year-old man is reported.
  • [MeSH-major] Ameloblastoma / pathology. Nose Neoplasms / pathology. Paranasal Sinus Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15723691.001).
  • [ISSN] 0903-4641
  • [Journal-full-title] APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
  • [ISO-abbreviation] APMIS
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


82. Sauk JJ, Nikitakis NG, Scheper MA: Are we on the brink of nonsurgical treatment for ameloblastoma? Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jul;110(1):68-78
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Are we on the brink of nonsurgical treatment for ameloblastoma?
  • OBJECTIVE: Recent identification of altered molecular signaling pathways in neoplasia has begun to elucidate mechanisms of oncogenesis, differentiation, and tumor progression, and to suggest plausible nonsurgical considerations for treatment.
  • Here we review the sonic hedgehog (SHH) and PI3K/Akt/mTOR signaling pathways, their role in ameloblastoma, a locally aggressive odontogenic tumor, and evidence for consideration of therapeutic approaches that target these molecular pathways.
  • STUDY DESIGN: This is a comprehensive review of the literature regarding alterations in signaling mechanisms associated with ameloblastomas.
  • In addition, this review attempts to explore and discuss possible inhibitors to these pathways that may have utility in treating ameloblastoma.
  • RESULTS: The expression of SHH signaling molecules in ameloblastomas at the mRNA and protein levels has intimated that these molecules may play a role in cell proliferation of these tumors.
  • Immunohistochemical analysis has revealed aberrant signaling in the PI3K/Akt/mTOR pathway in ameloblastomas and appears to be a valuable tool for elucidating pathogenesis and aggressiveness, and selecting optimal therapeutics.
  • CONCLUSION: The understanding of altered pathways in ameloblastoma may soon provide nonsurgical options for the treatment of this condition.
  • [MeSH-major] Ameloblastoma / drug therapy. Signal Transduction / drug effects

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2010 Mosby, Inc. All rights reserved.
  • (PMID = 20418126.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / GLI1 protein, human; 0 / Hedgehog Proteins; 0 / Intracellular Signaling Peptides and Proteins; 0 / SHH protein, human; 0 / Transcription Factors; EC 2.7.1.- / Phosphatidylinositol 3-Kinases; EC 2.7.1.1 / MTOR protein, human; EC 2.7.1.1 / TOR Serine-Threonine Kinases; EC 2.7.11.1 / Protein-Serine-Threonine Kinases; EC 2.7.11.1 / Proto-Oncogene Proteins c-akt
  •  go-up   go-down


83. Ramesh RS, Manjunath S, Ustad TH, Pais S, Shivakumar K: Unicystic ameloblastoma of the mandible--an unusual case report and review of literature. Head Neck Oncol; 2010;2:1

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unicystic ameloblastoma of the mandible--an unusual case report and review of literature.
  • Ameloblastoma is a true neoplasm of odontogenic epithelial origin.
  • Its incidence, combined with its clinical behavior, makes ameloblastoma the most significant odontogenic neoplasm.
  • Unicystic ameloblastoma (UA) refers to those cystic lesions that show clinical, radiographic, or gross features of a mandibular cyst, but on histologic examination show a typical ameloblastomatous epithelium lining part of the cyst cavity, with or without luminal and/or mural tumor growth.
  • It accounts for 5-15% of all intraosseous ameloblastomas.
  • We report a case of unicystic ameloblastoma in a 30-year-old female, and review the literature.
  • [MeSH-major] Ameloblastoma / pathology. Mandibular Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Oral Maxillofac Surg. 2006 Aug;35(8):681-90 [16782308.001]
  • [Cites] J Oral Maxillofac Surg. 2002 Feb;60(2):211-5 [11815925.001]
  • [Cites] Zhonghua Kou Qiang Yi Xue Za Zhi. 2002 May;37(3):210-2 [12419147.001]
  • [Cites] Plast Reconstr Surg. 2004 Jan;113(1):80-7 [14707625.001]
  • [Cites] Dentomaxillofac Radiol. 2004 Jan;33(1):60-2 [15140824.001]
  • [Cites] Histopathology. 1995 Mar;26(3):219-28 [7797199.001]
  • [Cites] J Dent Assoc S Afr. 1994 Nov;49(11):559-62 [9508960.001]
  • [Cites] Arch Pathol Lab Med. 1998 Apr;122(4):371-4 [9648908.001]
  • [Cites] J Craniofac Surg. 2006 Jan;17(1):178-82 [16432430.001]
  • [Cites] Oral Oncol. 2006 May;42(5):481-6 [16488178.001]
  • (PMID = 20157425.001).
  • [ISSN] 1758-3284
  • [Journal-full-title] Head & neck oncology
  • [ISO-abbreviation] Head Neck Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2821325
  • [General-notes] NLM/ Original DateCompleted: 20100629
  •  go-up   go-down


84. Jiang LJ, Shao CK, He D, Li WG, Wu XZ, Cai DZ: [Correlations of extrocellular matrix metalloproteinase inducer and microvessel density to invasiveness of ameloblastoma]. Ai Zheng; 2008 Dec;27(12):1263-6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Correlations of extrocellular matrix metalloproteinase inducer and microvessel density to invasiveness of ameloblastoma].
  • BACKGROUND & OBJECTIVE: Matrix metalloproteinases (MMPs) are involved in local invasion of ameloblastomas.
  • This study was to evaluate the role of matrix metalloproteinase inducer (EMMPRIN) in angiogenesis in ameloblastomas by analyzing EMMPRIN expression and microvessel density (MVD) in ameloblastomas and odontogenic cysts.
  • METHODS: EMMPRIN expression and MVD in 41 specimens of ameloblastoma and 40 specimens of odontogenic cyst were examined by SP immuno-histochemistry.
  • RESULTS: EMMPRIN was detected in all specimens of ameloblastomas and odontogenic cysts.
  • The strong positive rate of EMMPRIN was significantly higher in ameloblastomas than in odontogenic cysts (85.4% vs. 62.5%, P<0.05).
  • CONCLUSION: EMMPRIN may play an important role during the progression of ameloblastoma via controlling angiogenesis and degradation of extracellular MMPs.
  • [MeSH-major] Ameloblastoma / metabolism. Antigens, CD147 / metabolism. Jaw Neoplasms / metabolism. Microvessels / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19079990.001).
  • [Journal-full-title] Ai zheng = Aizheng = Chinese journal of cancer
  • [ISO-abbreviation] Ai Zheng
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 136894-56-9 / Antigens, CD147
  •  go-up   go-down


85. de Souza Andrade ES, Miguel MC, de Almeida Freitas R, Pereira Pinto L, Batista de Souza L: Immunoexpression of integrins in ameloblastoma, adenomatoid odontogenic tumor, and human tooth germs. Int J Surg Pathol; 2008 Jul;16(3):277-85

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Immunoexpression of integrins in ameloblastoma, adenomatoid odontogenic tumor, and human tooth germs.
  • The expression of integrins alpha2beta1, alpha3beta1, and alpha5beta1 in 30 ameloblastomas (20 solid and 10 unicystic tumors), 12 adenomatoid odontogenic tumors (AOTs), and 5 human tooth germs in different stages of odontogenesis was analyzed.
  • No difference in the immunoexpression of the integrins was observed between solid and unicystic ameloblastomas.
  • When these two ameloblastoma types were pooled into a single group, the following significant differences were found: immunoexpression of integrin alpha2beta1 was stronger in ameloblastomas than in AOTs and tooth germs, and the expression of integrin alpha5beta1 was stronger in ameloblastomas than in AOTs.
  • [MeSH-major] Ameloblastoma / metabolism. Biomarkers, Tumor / metabolism. Jaw Neoplasms / metabolism. Receptors, Collagen / metabolism. Tooth Germ / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18573784.001).
  • [ISSN] 1066-8969
  • [Journal-full-title] International journal of surgical pathology
  • [ISO-abbreviation] Int. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Integrin alpha2beta1; 0 / Integrin alpha3beta1; 0 / Integrin alpha5beta1; 0 / Receptors, Collagen
  •  go-up   go-down


86. Wang YP, Liu BY: Expression of osteopontin and its receptors in ameloblastomas. Oral Oncol; 2009 Jun;45(6):538-42

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of osteopontin and its receptors in ameloblastomas.
  • This study used an immunohistochemical method to examine the expression of osteopontin (OPN) in 30 ameloblastomas and of integrin alpha(v) and CD44v6 in 20 of these 30 ameloblastomas.
  • We found that the positive staining rate in ameloblastomas was 87% for OPN, 45% for integrin alpha(v), and 90% for CD44v6.
  • In addition, binding of OPN to ameloblastoma tumor cell membrane receptor CD44v6 can enhance tumor cell migration, invasion and spread.
  • Therefore, we suggest that the local aggressive behavior and high osteolytic ability of ameloblastomas in the jawbones can be explained by the high expression of OPN and CD44v6 in ameloblastoma cells and the high expression of integrin alpha(v) in osteoclasts.
  • [MeSH-major] Ameloblastoma / metabolism. Antigens, CD44 / metabolism. Integrin alphaV / metabolism. Jaw Neoplasms / metabolism. Neoplasm Proteins / metabolism. Osteopontin / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18804406.001).
  • [ISSN] 1879-0593
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, CD44; 0 / CD44v6 antigen; 0 / Integrin alphaV; 0 / Neoplasm Proteins; 106441-73-0 / Osteopontin
  •  go-up   go-down


87. Hayes MI, Prince SE: Peripheral ameloblastoma: a case report. Dent Update; 2006 Dec;33(10):624-5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Peripheral ameloblastoma: a case report.
  • Peripheral ameloblastoma is an uncommon pathological variant of the more usual intraosseous central ameloblastoma.
  • There was no evidence of bony involvement on radiographs but it was revealed histologically to be a peripheral ameloblastoma.
  • [MeSH-major] Ameloblastoma / diagnosis. Gingival Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17209538.001).
  • [ISSN] 0305-5000
  • [Journal-full-title] Dental update
  • [ISO-abbreviation] Dent Update
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


88. Simon EN, Merkx MA, Kalyanyama BM, Shubi FM, Stoelinga PJ: Evaluation of quality of life among patients after extirpation of mandibular ameloblastoma. East Afr Med J; 2005 Jun;82(6):314-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Evaluation of quality of life among patients after extirpation of mandibular ameloblastoma.
  • OBJECTIVE: To evaluate the quality of life (QOL) based on the functional, aesthetic and personal satisfaction among patients with ameloblastoma who underwent either partial or total mandibulectomy without reconstruction.
  • SUBJECTS: Patients surgically treated for ameloblastoma without reconstruction.
  • [MeSH-major] Ameloblastoma / surgery. Mandibular Neoplasms / surgery. Oral Surgical Procedures / adverse effects. Patient Satisfaction. Quality of Life

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16175784.001).
  • [ISSN] 0012-835X
  • [Journal-full-title] East African medical journal
  • [ISO-abbreviation] East Afr Med J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Kenya
  •  go-up   go-down


89. Leibovitch I, Schwarcz RM, Modjtahedi S, Selva D, Goldberg RA: Orbital invasion by recurrent maxillary ameloblastoma. Ophthalmology; 2006 Jul;113(7):1227-30

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Orbital invasion by recurrent maxillary ameloblastoma.
  • PURPOSE: To describe 2 patients with orbital invasion by maxillary ameloblastoma, a rare odontogenic tumor that is not commonly encountered in ophthalmic practice.
  • METHODS: Two patients who were diagnosed with maxillary ameloblastoma several years ago sought treatment for new-onset ocular and orbital signs and symptoms.
  • RESULTS: In the first patient, tumor recurrence with orbital invasion was diagnosed, and the patient underwent a total orbital exenteration.
  • CONCLUSIONS: Although a slow-growing tumor, maxillary ameloblastoma can recur after surgical excision and can be locally aggressive; it can invade the orbit and result in significant ocular morbidity.
  • Ophthalmologists should be aware of this tumor and should monitor these patients closely when orbital invasion is suspected.
  • [MeSH-major] Ameloblastoma / pathology. Maxillary Neoplasms / pathology. Neoplasm Recurrence, Local / pathology. Orbital Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16757029.001).
  • [ISSN] 1549-4713
  • [Journal-full-title] Ophthalmology
  • [ISO-abbreviation] Ophthalmology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


90. Kitkumthorn N, Yanatatsaneejit P, Rabalert J, Dhammawipark C, Mutirangura A: Association of P53 codon 72 polymorphism and ameloblastoma. Oral Dis; 2010 Oct;16(7):631-5
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Association of P53 codon 72 polymorphism and ameloblastoma.
  • OBJECTIVE: To test the hypothesis that P53 codon 72 polymorphism was associated with an increased risk of developing ameloblastoma in the Thai population.
  • MATERIALS AND METHODS: Seventy-eight ameloblastomas and 94 healthy controls were genotyped for the P53 codon 72 by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).
  • RESULTS: The frequencies of the Arg/Arg, Arg/Pro and Pro/Pro genotypes were 28.72%, 50.00% and 21.28%, respectively, in the controls; and 44.87%, 51.28% and 3.85%, respectively, in ameloblastomas.
  • Therefore, P53 Arg is an ameloblastoma-susceptible allele [OR (95% CI) = 2.06 (1.28-3.31), P = 0.002].
  • Moreover, when compared with homozygous P53 Pro, people who carried the Arg allele had a remarkably high risk of developing ameloblastoma [adjusted OR (95% CI) = 7.26 (2.34-23.41), P < 10(-3)].
  • CONCLUSION: The Arg allele of P53 gene codon 72 may increase susceptibility, and P53 may be important in the aetiology of ameloblastoma.
  • [MeSH-major] Ameloblastoma / genetics. Codon / genetics. Polymorphism, Restriction Fragment Length / genetics. Tumor Suppressor Protein p53 / genetics
  • [MeSH-minor] Alleles. Arginine / genetics. Cytosine. Double-Blind Method. Female. Gene Frequency / genetics. Genetic Predisposition to Disease / genetics. Genotype. Guanine. Homozygote. Humans. Male. Polymerase Chain Reaction. Proline / genetics. Sex Factors. Thailand

  • Hazardous Substances Data Bank. (L)-PROLINE .
  • Hazardous Substances Data Bank. GUANINE .
  • Hazardous Substances Data Bank. (L)-ARGININE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20412452.001).
  • [ISSN] 1601-0825
  • [Journal-full-title] Oral diseases
  • [ISO-abbreviation] Oral Dis
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Codon; 0 / TP53 protein, human; 0 / Tumor Suppressor Protein p53; 5Z93L87A1R / Guanine; 8J337D1HZY / Cytosine; 94ZLA3W45F / Arginine; 9DLQ4CIU6V / Proline
  •  go-up   go-down


91. Keskin M, Karabekmez FE, Ozkan BT, Tosun Z, Avunduk MC, Savaci N: Simultaneous occurrence of facial fibrous dysplasia and ameloblastoma. J Craniomaxillofac Surg; 2009 Mar;37(2):102-5
Genetic Alliance. consumer health - Fibrous Dysplasia.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Simultaneous occurrence of facial fibrous dysplasia and ameloblastoma.
  • BACKGROUND: Both fibrous dysplasia (FD) and ameloblastoma are benign but locally aggressive tumours of the craniofacial region.
  • She was diagnosed as FD of the maxilla, temporal bone and sphenoid sinus together with ameloblastoma of the mandible after surgery and histopathological evaluation.
  • CONCLUSION: The case that we present here is unique in that two separate pathological conditions, FD of the upper face, and ameloblastoma of the mandible coexisted.
  • Although cases of synchronous or metachronous occurrence of FD and ameloblastoma with other pathology have been previously described, this to our knowledge, is the first reported case of true coexistence of FD and ameloblastoma.
  • [MeSH-major] Ameloblastoma / complications. Fibrous Dysplasia, Monostotic / complications. Mandibular Neoplasms / complications. Maxillary Diseases / complications

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19064325.001).
  • [ISSN] 1010-5182
  • [Journal-full-title] Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
  • [ISO-abbreviation] J Craniomaxillofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


92. de Medeiros AM, Nonaka CF, Galvão HC, de Souza LB, Freitas Rde A: Expression of extracellular matrix proteins in ameloblastomas and adenomatoid odontogenic tumors. Eur Arch Otorhinolaryngol; 2010 Feb;267(2):303-10
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of extracellular matrix proteins in ameloblastomas and adenomatoid odontogenic tumors.
  • This study evaluated the expression of fibronectin, tenascin and type I collagen in ameloblastomas and adenomatoid odontogenic tumors (AOTs) aiming to contribute with the comprehension of the differences in the biological behavior of these tumors.
  • Immunohistochemical technique was performed in 20 cases of ameloblastoma (16 solid and 4 desmoplastic) and in 10 cases of AOT.
  • Solid ameloblastomas showed intense expression of fibronectin at the epithelial-mesenchymal interface, whereas desmoplastic ameloblastomas revealed no immunoexpression of fibronectin at this site.
  • Ameloblastomas presented stronger immunoreactivity to tenascin than AOTs, especially at the epithelial-mesenchymal interface.
  • AOTs and desmoplastic ameloblastomas showed intense labeling for type I collagen.
  • The patterns of expression of the proteins studied agree with the locally more invasive behavior of ameloblastomas in comparison to AOTs.
  • Our results might suggest a less invasive behavior of desmoplastic ameloblastoma in comparison to solid ameloblastoma.
  • [MeSH-major] Adenomatoid Tumor / metabolism. Ameloblastoma / metabolism. Collagen Type I / biosynthesis. Fibronectins / biosynthesis. Jaw Neoplasms / metabolism. Odontogenic Tumors / metabolism. Tenascin / biosynthesis
  • [MeSH-minor] Biomarkers, Tumor / biosynthesis. Extracellular Matrix Proteins / biosynthesis. Humans. Immunohistochemistry. Prognosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Biochem Cell Biol. 2004 Jun;36(6):986-90 [15094113.001]
  • [Cites] Int J Biochem Cell Biol. 2005 May;37(5):1066-83 [15743679.001]
  • [Cites] Biochim Biophys Acta. 2000 Mar 27;1470(2):O9-20 [10722930.001]
  • [Cites] Virchows Arch. 2002 Aug;441(2):165-73 [12189507.001]
  • [Cites] Cancer Lett. 2006 Dec 8;244(2):143-63 [16632194.001]
  • [Cites] J Cell Sci. 2007 Jun 15;120(Pt 12):1955-8 [17550969.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Jun;91(6):649-53 [11402276.001]
  • [Cites] J Cell Biol. 1997 Jun 16;137(6):1445-57 [9182674.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Nov;104(5):666-75 [17150384.001]
  • [Cites] Histopathology. 2004 Jul;45(1):65-72 [15228445.001]
  • [Cites] Virchows Arch B Cell Pathol Incl Mol Pathol. 1991;61(2):101-9 [1720587.001]
  • [Cites] Biochem Soc Trans. 2004 Feb;32(Pt 1):17-20 [14748704.001]
  • [Cites] Eur J Cancer B Oral Oncol. 1995 Jul;31B(4):275-9 [7492926.001]
  • [Cites] J Oral Maxillofac Surg. 1984 Nov;42(11):735-40 [6593446.001]
  • [Cites] J Endod. 1997 Sep;23(9):565-8 [9587282.001]
  • [Cites] Eur J Cancer B Oral Oncol. 1996 Sep;32B(5):328-32 [8944836.001]
  • [Cites] Virchows Arch. 2000 Apr;436(4):319-23 [10834533.001]
  • [Cites] J Oral Pathol Med. 2007 Nov;36(10 ):609-14 [17944754.001]
  • [Cites] Braz J Otorhinolaryngol. 2006 Sep-Oct;72(5):709-13 [17221066.001]
  • [Cites] Oral Oncol. 2000 Jul;36(4):365-72 [10899676.001]
  • [Cites] Oral Oncol. 2001 Jul;37(5):455-60 [11377234.001]
  • [Cites] J Oral Pathol Med. 2006 Mar;35(3):183-9 [16454815.001]
  • [Cites] Arch Oral Biol. 2003 Oct;48(10):709-16 [12971948.001]
  • [Cites] Int J Oral Maxillofac Surg. 2006 Aug;35(8):750-5 [16690252.001]
  • [Cites] J Oral Pathol Med. 2000 Nov;29(10):483-90 [11048964.001]
  • [Cites] Ann Diagn Pathol. 2007 Jun;11(3):199-205 [17498594.001]
  • [Cites] Curr Opin Cell Biol. 2006 Oct;18(5):463-71 [16919434.001]
  • [Cites] Eur J Cancer. 2002 Dec;38(18):2362-70 [12460779.001]
  • [Cites] J Oral Pathol Med. 2004 Jul;33(6):354-9 [15200484.001]
  • [Cites] Oral Oncol. 1999 Mar;35(2):125-31 [10435145.001]
  • [Cites] Eur J Cancer B Oral Oncol. 1994 May;30B(3):191-5 [7522711.001]
  • [Cites] Int J Oral Maxillofac Surg. 2007 Aug;36(8):671-9 [17643963.001]
  • [Cites] Int J Surg Pathol. 2008 Jul;16(3):277-85 [18573784.001]
  • [Cites] J Clin Periodontol. 2007 Aug;34(8):691-708 [17590157.001]
  • (PMID = 19466441.001).
  • [ISSN] 1434-4726
  • [Journal-full-title] European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
  • [ISO-abbreviation] Eur Arch Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Collagen Type I; 0 / Extracellular Matrix Proteins; 0 / Fibronectins; 0 / Tenascin
  •  go-up   go-down


93. Ribeiro BF, Iglesias DP, Nascimento GJ, Galvão HC, Medeiros AM, Freitas RA: Immunoexpression of MMPs-1, -2, and -9 in ameloblastoma and odontogenic adenomatoid tumor. Oral Dis; 2009 Oct;15(7):472-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Immunoexpression of MMPs-1, -2, and -9 in ameloblastoma and odontogenic adenomatoid tumor.
  • OBJECTIVE: The aim of this study was to evaluate and compare the expression of metalloproteinases-1, -2, and -9 in solid ameloblastoma and adenomatoid odontogenic tumor.
  • METHODS: A total of 20 cases of solid ameloblastoma and 10 cases of adenomatoid odontogenic tumors were selected and immunohistochemically assessed.
  • For MMP-2, there was a varied expression, with 80% and 60% of immunoreactive tumor cells in ameloblastoma and adenomatoid odontogenic tumor respectively.
  • Regarding stromal cells, 65% of ameloblastomas and 80% of adenomatoid odontogenic tumors showed positivity.
  • A statistically significant difference in the expression of MMP-1 in relation to the expression of MMP-2 and -9 in ameloblastomas (P < 0.001) was observed.
  • CONCLUSION: The results suggest that these metalloproteinases are related to growth and progression of tumors analyzed, and particularly in ameloblastoma, its highest aggressiveness may be, in part, a result of the active participation of the stromal cells and their products, such as the MMPs studied.
  • [MeSH-major] Ameloblastoma / metabolism. Matrix Metalloproteinase 1 / biosynthesis. Matrix Metalloproteinase 2 / biosynthesis. Matrix Metalloproteinase 9 / biosynthesis. Odontogenic Tumors / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19522745.001).
  • [ISSN] 1601-0825
  • [Journal-full-title] Oral diseases
  • [ISO-abbreviation] Oral Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] EC 3.4.24.24 / Matrix Metalloproteinase 2; EC 3.4.24.35 / Matrix Metalloproteinase 9; EC 3.4.24.7 / Matrix Metalloproteinase 1
  •  go-up   go-down


94. Kumamoto H, Ohki K: Detection of Notch signaling molecules in ameloblastomas. J Oral Pathol Med; 2008 Apr;37(4):228-34
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Detection of Notch signaling molecules in ameloblastomas.
  • BACKGROUND: To evaluate the roles of Notch signaling in the oncogenesis and cytodifferentiation of odontogenic tumors, expression of Notch receptors and ligands was analyzed in ameloblastomas as well as in tooth germs.
  • METHODS: Tissue specimens of nine tooth germs and 32 ameloblastomas were examined by reverse transcriptase polymerase chain reaction and by in situ hybridization to determine the expression of Notch1, Notch2, Notch3, Delta1, and Jagged1.
  • Ameloblastomas showed expression of Notch receptors and ligands in central polyhedral neoplastic cells.
  • Expression of Notch receptors and ligands was not found in keratinizing cells or granular cells in ameloblastoma variants.
  • CONCLUSION: Expression of Notch receptors and ligands in tooth germs and ameloblastomas suggests that Notch signaling might control cell differentiation and proliferation of normal and neoplastic odontogenic epithelium.
  • [MeSH-major] Ameloblastoma / chemistry. Intercellular Signaling Peptides and Proteins / analysis. Jaw Neoplasms / chemistry. Receptors, Notch / analysis. Tooth Germ / chemistry

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18221321.001).
  • [ISSN] 1600-0714
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Intercellular Signaling Peptides and Proteins; 0 / RNA, Messenger; 0 / Receptors, Notch
  •  go-up   go-down


95. Siar CH, Nakano K, Han PP, Nagatsuka H, Ng KH, Kawakami T: Differential expression of Notch receptors and their ligands in desmoplastic ameloblastoma. J Oral Pathol Med; 2010 Aug 1;39(7):552-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Differential expression of Notch receptors and their ligands in desmoplastic ameloblastoma.
  • The ameloblastoma, a benign odontogenic epithelial neoplasm, histologically recapitulates the enamel organ at bell stage.
  • Notch has been detected in the plexiform and follicular ameloblastoma.
  • Its activity in the desmoplastic ameloblastoma is unknown.
  • METHOD: Notch1-4 and their ligands (Jagged1, Jagged2 and Delta1) were examined immunohistochemically in 10 cases of desmoplastic ameloblastoma.
  • RESULTS: Ameloblastoma tumor epithelium demonstrated positive expression for Notch1 (n = 5/10), Notch3 (n = 8/10), Notch4 (n = 10/10), Jagged1 (n = 6/10) and Delta1 (n = 5/10), but no reactivity for Notch2 (n = 10/10) and Jagged2 (10/10).
  • CONCLUSIONS: These findings suggest that Notch receptors and their ligands may play differing roles during the development of the desmoplastic ameloblastoma with Notch4 probably playing a greater role in the acquisition of tissue-specific cellular characteristics in the desmoplastic ameloblastoma.
  • [MeSH-major] Ameloblastoma / pathology. Receptors, Notch / analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20337864.001).
  • [ISSN] 1600-0714
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Calcium-Binding Proteins; 0 / Intercellular Signaling Peptides and Proteins; 0 / Intracellular Signaling Peptides and Proteins; 0 / JAG2 protein, human; 0 / Ligands; 0 / Membrane Proteins; 0 / NOTCH1 protein, human; 0 / NOTCH2 protein, human; 0 / NOTCH3 protein, human; 0 / NOTCH4 protein, human; 0 / Proto-Oncogene Proteins; 0 / Receptor, Notch1; 0 / Receptor, Notch2; 0 / Receptors, Notch; 0 / delta protein; 134324-36-0 / Serrate proteins
  •  go-up   go-down


96. Bologna-Molina R, Mosqueda-Taylor A, Lopez-Corella E, Almeida OP, Carrasco-Daza D, Garcia-Vazquez F, Farfan-Morales JE, Irigoyen-Camacho ME, Damián-Matsumura P: Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas. Oral Oncol; 2008 Aug;44(8):805-11

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas.
  • Ameloblastoma is the most frequent odontogenic tumor and is considered a benign, but locally invasive, neoplasm with variable clinico-pathological expression.
  • The aims of this study were to examine the pattern of syndecan-1 expression, to evaluate the proliferating activity in a large series of solid/multicystic (SA) and unicystic ameloblastomas (UA), and to study its possible correlation to their biological behavior.
  • Immunohistochemical studies were performed for syndecan-1 (clone MI15) and Ki-67 (clone MIB-1) in 120 ameloblastomas (75 SA and 45 UA).
  • The salient finding was that expression of syndecan-1 was related to the histological subtype of tumors, as there was a lower expression in SA (40.2%) as compared to UA (49.7%) (p<0.05).
  • These findings did not correlate with Ki-67 expression, as this was similar in both types of ameloblastomas.
  • The lack of correlation between reduction of the syndecan-1 and Ki-67 index may be due to the different histomorphologies of both types of ameloblastoma, and more studies are necessary to better understand the role of this protein in the biological behavior of these tumors.
  • [MeSH-major] Ameloblastoma / metabolism. Ki-67 Antigen / metabolism. Neoplasm Proteins / metabolism. Syndecan-1 / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18207448.001).
  • [ISSN] 1368-8375
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Ki-67 Antigen; 0 / Neoplasm Proteins; 0 / Syndecan-1
  •  go-up   go-down


97. Ide F, Mishima K, Miyazaki Y, Saito I, Kusama K: Peripheral ameloblastoma in-situ: an evidential fact of surface epithelium origin. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Nov;108(5):763-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Peripheral ameloblastoma in-situ: an evidential fact of surface epithelium origin.
  • The proposed origin from the adult gingival epithelium for peripheral ameloblastoma is difficult to prove and still remains unresolved.
  • In addition to the morphologic overlap, early ameloblastoma epithelia shared antigenic properties with tumor cells of representative control examples of peripheral ameloblastoma.
  • This is the first description of an in situ lesion of peripheral ameloblastoma, to our knowledge, and its multifocal ameloblastoma changes can be accepted as a direct proof of origin from the surface epithelium.
  • [MeSH-major] Ameloblastoma / pathology. Gingival Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 May;109(5):655-6; author reply 656-7 [20416531.001]
  • (PMID = 19748296.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Neoplasm
  •  go-up   go-down


98. Sun ZJ, Wu YR, Cheng N, Zwahlen RA, Zhao YF: Desmoplastic ameloblastoma - A review. Oral Oncol; 2009 Sep;45(9):752-9
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Desmoplastic ameloblastoma - A review.
  • Among the ameloblastomas, the desmoplastic variation is rare.
  • The desmoplastic ameloblastoma (DA) is characterized by specific clinical, imaging, and histological features.
  • In conclusion, these retrospective results confirm the statement that DA is a variation among ameloblastomas.
  • DA present clinicoradiographic and histologic distinct features, when compared with "conventional ameloblastomas".
  • [MeSH-major] Ameloblastoma / epidemiology. Mandibular Neoplasms / epidemiology. Maxillary Neoplasms / epidemiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19631576.001).
  • [ISSN] 1879-0593
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] England
  •  go-up   go-down


99. Smullin SE, Faquin W, Susarla SM, Kaban LB: Peripheral desmoplastic ameloblastoma: report of a case and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jan;105(1):37-40
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Peripheral desmoplastic ameloblastoma: report of a case and literature review.
  • The desmoplastic variant of ameloblastoma is a rare, locally invasive, benign tumor of the jaws, typically found in the anterior regions of the maxilla and mandible.
  • This ameloblastoma variant has been described as an intraosseous tumor; to our knowledge, there have been no published cases of a peripheral desmoplastic ameloblastoma.
  • The purpose of this case report is to describe a patient with a desmoplastic ameloblastoma localized to the soft tissue of the palate with no osseous involvement.
  • [MeSH-major] Ameloblastoma / pathology. Palatal Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17764981.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 14
  •  go-up   go-down


100. Adebiyi KE, Ugboko VI, Omoniyi-Esan GO, Ndukwe KC, Oginni FO: Clinicopathological analysis of histological variants of ameloblastoma in a suburban Nigerian population. Head Face Med; 2006;2:42

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinicopathological analysis of histological variants of ameloblastoma in a suburban Nigerian population.
  • BACKGROUND: This study was carried out to establish the relative incidence and provide clinico-pathologic information on the various histological types of ameloblastoma seen at the Obafemi Awolowo University Teaching Hospital complex, Ile-Ife in order to provide a baseline data which will be of significance to the pathologist and clinician.
  • METHODS: Clinico-pathologic data on a total of 77 histologically diagnosed cases of ameloblastoma archieved at the Obafemi Awolowo University Teaching Hospital Complex, Ile-Ife over a 15 year period were obtained and analysed descriptively.
  • RESULTS: Follicular ameloblastoma was the most common histological type (50 cases, 64.9%), followed by plexiform ameloblastoma (10 cases, 13.0%).
  • 4 (5.2%) cases of desmoplastic and 3 (3.9%) cases of acanthomatous ameloblastoma were seen while the basal cell variant accounted for 2 (2.6%) cases.
  • Ameloblastoma occurred over an age range of 11 to 70 years with a peak age incidence in the 3rd decade.
  • CONCLUSION: This study provides a baseline data on variants of ameloblastoma as obtained in a suburban Nigerian population.
  • Since variants of ameloblastoma differ in biologic behaviour, the data collected in this study provides clinicopathologic information which is of significance to the pathologist and clinician.
  • [MeSH-major] Ameloblastoma / pathology. Jaw Neoplasms / pathology. Suburban Population

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Oral Surg Oral Med Oral Pathol. 1967 Sep;24(3):392-403 [5233386.001]
  • [Cites] West Afr Med J Niger Pract. 1968 Apr;17(2):45-9 [5655728.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1975 Oct;40(4):502-21 [1058441.001]
  • [Cites] J Oral Surg. 1978 Oct;36(10):771-8 [280645.001]
  • [Cites] Int J Oral Surg. 1981 Aug;10(4):255-60 [6809655.001]
  • [Cites] J Oral Maxillofac Surg. 1985 Sep;43(9):707-17 [3861827.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1987 Jan;63(1):78-84 [3468468.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1987 Apr;63(4):441-51 [3472145.001]
  • [Cites] Aust Dent J. 1990 Dec;35(6):518-22 [2090083.001]
  • [Cites] Dent Update. 1991 Sep;18(7):309-12 [1810789.001]
  • [Cites] Eur J Cancer B Oral Oncol. 1993 Jul;29B(3):169-71 [8298419.001]
  • [Cites] J Oral Pathol Med. 1995 Nov;24(10):454-7 [8600281.001]
  • [Cites] Int J Oral Maxillofac Surg. 2004 Dec;33(8):766-70 [15556324.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 Feb;99(2):191-5 [15660091.001]
  • [Cites] Quintessence Int. 2006 Jan;37(1):69-74 [16429706.001]
  • [Cites] Acta Cytol. 2000 Jan-Feb;44(1):81-5 [10667166.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1987 Jun;63(6):688-97 [3295656.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Jun;91(6):649-53 [11402276.001]
  • [Cites] Pesqui Odontol Bras. 2001 Oct-Dec;15(4):308-13 [11787319.001]
  • [Cites] Am J Surg Pathol. 2000 Oct;24(10):1385-92 [11023100.001]
  • [Cites] J Oral Maxillofac Surg. 2003 Sep;61(9):1004-10 [12966474.001]
  • [Cites] J Oral Pathol Med. 2002 Aug;31(7):415-20 [12165060.001]
  • (PMID = 17125498.001).
  • [ISSN] 1746-160X
  • [Journal-full-title] Head & face medicine
  • [ISO-abbreviation] Head Face Med
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1675998
  • [General-notes] NLM/ Original DateCompleted: 20070724
  •  go-up   go-down






Advertisement